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The future of diagnostics and therapeutic drugs in biomedicine is nanoparticles. 
These nanoparticles come in many different shapes, sizes, and combination of materials. 
Magnetic nanoparticles have been studied for many years for use in biomedicine, not 
only for their high surface area, but also because of its unique magnetic properties. They 
can magnetically interact with their environment, be guided to a specific location, and 
manipulated to release energy in the form of heat. To ensure that these magnetic 
nanoparticles survive in the circulatory system, they must be modified with materials to 
make them colloidally stable in water and shield them from the body’s immune response 
to foreign objects. 
The purpose of this project is to design and synthesize a ligand for the 
modification of iron oxide nanoparticles with three important characteristics: 1) water-
dispersable, 2) biologically stable, and 3) functional surface. This was accomplished by 
synthesizing specialized heterobifunctional polyethylene oxide (PEO) that has a catechol 
on one end to bind strongly to iron oxide nanoparticles and an alkyne on the other end to 
provide further functionality. This design allows for easy customization of the particles 
surface, using “click chemistry,” with targeting and fluorescent moieties for any desired 
application.  
The work reported discusses the techniques used for synthesizing a variety of 
heterobifunctional PEO via anionic ring opening polymerization of ethylene oxide and 
subsequent end group modifications that ultimately led to the design of a universal ligand 
for iron oxide nanoparticles, with improved stability in biological environments, that can 
 ii 
be used in many biomedical applications. These universal magnetic nanoparticles were 
modified with different fluorescent dyes for imaging biofilms, carbohydrates for targeting 
bacteria, and radiotracers for multifunctional diagnostic probes to demonstrate the 
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Nanotechnology provides a unique approach to solving some of the world’s 
biggest problems. One of the largest research areas currently utilizing nanotechnology in 
the form of nanoparticles, particles smaller than 100 nm, is biomedicine. Typically these 
nanoparticles are used as a vessel for carrying therapeutic drugs for treatment or 
diagnostic dyes for imaging because of the large surface area available to carry these 
agents. Much work has been done into the synthesis of nanoparticles using inorganic, 
magnetic materials that adds magnetic component that can be manipulated in a magnetic 
field. For biomedicine, they offer a new functionality that can be taken advantage of for 
delivery (magnetic targeting), therapy (magnetic hyperthermia), and diagnostics (contrast 
agents) that was not available before. Unfortunately, many of these magnetic 
nanoparticles are synthesized using hydrophobic ligands that are incompatible for 
biomedical applications and require water-soluble coatings to improve biocompatibility. 
This chapter will provide background information about the different types of inorganic 
materials used in magnetic nanoparticles, surface coatings used to make them more 
biocompatible, how their size and surface can affect delivery and treatment, the 
importance of polyethylene oxide (PEO) for biological stability of drugs, and how “click 




1.2. MAGNETIC HYPERTHERMIA  
 
The application of alternating magnetic fields to magnetic materials, known as 
magnetic hyperthermia, was first investigated by Gilchrist et al. in 1957.1 The general 
procedure for magnetic hyperthermia involves the accumulation of magnetic 
nanoparticles via the local application of a magnetic field or surface functionalization 
with targeting ligands that specifically bind to cell or tissue receptors after systemic or 
local administration.  Once the magnetic nanoparticles (MNPs) are in the desired location, 
an alternating magnetic field of specified field and frequency is applied to generate heat 
and increase the temperature of the surrounding diseased tissue.  Ideally, the tissue is 
heated to approximately 42ºC for at least 30 minutes.2 This targeted “fever” results in the 
destruction of cancer or other unwanted cells and tissue.  Magnetic hyperthermia has 
been successively demonstrated in numerous cancerous treatments in vitro and in vivo, 
such as melanoma,3 glioma,4 and human colonic adenocarcinoma.5  
1.3. INORGANIC MAGNETIC NANOPARTICLES USED IN BIOMEDICAL 
APPLICATIONS 
 
Since metal-oxides were synthesized into nanoparticles, they have been of interest 
in the medical field for use in imaging and drug delivery due to their response to applied 
magnetic fields. Examples of different inorganic nanometer sized particles developed for 
magnetic applications are iron platinum,6-10 iron palladium,11 cobalt platinum,12,13 cobalt 
oxide,14 and manganese based nanoparticles.15,16 Although these particles exhibit superior 
magnetic properties, they are not as biocompatible as iron oxide based nanoparticles 
(IONP),17 i.e. magnetite (Fe3O4),18 and maghemite (γ-Fe2O3).19 IONPs have been used for 
years in magnetic resonance imaging (MRI) contrast agents to improve medical 
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diagnostics.20,21 There has also been recent interest in the use of these same particles in 
magnetic cell separation22,23 and magnetic hyperthermia for cancer therapy.2,24-26 
Other substituted ferrites, CoFe2O4,26 MnFe2O4,27 and NiFe2O4 28 are being 
studied for their use in contrast agents and magnetic hyperthermia because of their high 
specific absorption rate (SAR) and biocompatibility once modified with a stabilizing 
layer. Pradhan et al. compared the magnetic heating properties and biocompatibility of 
Fe3O4, CoFe2O4, and MnFe2O4 modified with lauric acid. They discovered that Fe3O4 and 
MnFe2O4 had the higher SARs, 120 and 97 W g-1 ferrite, respectively. CoFe2O4 not only 
had the lowest SAR at 37 W g-1 ferrite, but the percent viability was the lowest for every 
concentration studied.29 Buckley et al. has also shown that nickel zinc ferrite 
nanoparticles can be used in shape memory polymers for medical stints and intravascular 
actuators.30  
Noble metals such as gold and silver have also been synthesized into 
nanoparticles that have distinct optical (e.g. plasmonic) and surface properties for 
biological applications.31 Gold is useful as a tracer and silver nanoparticles are very 
strong light absorbers and scatterers.25,32-34 These nanoparticles are used in catalysis and 
chemical sensing, as shells for magnetic nanoparticles to improve ligand binding, and in 
exploiting magnetic and optical properties.35,36 These properties make them ideal for 
biological conjugation and labeling applications using photothermal imaging, dark field 
microscopy, and fluorescent microscopy.37 
Metal oxide magnetic nanoparticles are synthesized using different methods based 
upon the application of the IONP system. One of the most common procedures used to 
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create IONPs involves co-precipitation of iron (II) chloride and iron (III) chloride from a 
basic solution in water.38,39 This method generally produces MNPs with a charged surface 
and polydispersity. More advanced synthetic methods have been developed to produce 
size controlled, monodispersed nanoparticles by the decomposition of metal precursors in 
high boiling point (~300ºC) solvents and surfactants.15,18 The surfactants that are 
generally used are fatty hydrocarbons that produce hydrophobic particles. These 
hydrophobic surfaces are unsuitable for the aqueous environment of the body and require 
further surface modification. 
1.4. NANOPARTICLE SIZE EFFECTS ON MAGNETIC NANOPARTICLES 
 
Literature suggests that Néel relaxation of the magnetic moments, (Figure 2A) has 
the most influence on the heating of single domain particles, whereas Brownian losses 
(Figure 2B) brought about by particle rotation against viscous forces do not contribute to 
frequencies suggested for medical applications; the MNPs must be larger.40 
 
Figure 1.1 (A) Néel relaxation and (B) Brownian motion mechanisms when exposed to 




In a recent study comparing the heating rates of 16 commercially available MNPs 
systems,41 the Pankhurst group found that the Resovist (Bayer-Schering) and Nanomag-
D-spio100 (MicroMod) particles produced the greatest power generated per mass. Both 
systems consist of clusters of 6-12 nm diameter IONPs coated with cyclodextran for a 
hydrodynamic diameter of 60-90 nm. Both also had high magnetic crystalline diameters 
determined via fitting of superconducting quantum interference device (SQUID) 
hysteresis loops. While these high crystalline diameters are perhaps due to single domain 
effects, this phenomenon could also indicate close particle clustering, resulting in 
behavior analogous to that of multi-domain structures. Such behavior supports the 
hypothesis that clustering nanoparticles are a major catalyst in the heating rate and 
efficiency in magnetic hyperthermia. Additional research on particle interaction affecting 
the heating rate and efficiency in magnetic hyperthermia has been reported.42 Particles 
with a small particle interaction radii determined by small angle neutron scattering 
(SANS) exhibited heating rates seven times as great as particles with larger radii.  The 
authors theorized that close interactions could significantly enhance dipole interactions as 
well confining heat output to a smaller area.42 Eggeman et al., comparing well-stabilized 
monodispersed particles to highly clustered commercially available particles, found that 
the clustered particles exhibited significantly greater heating than their well dispersed 
counterparts.43 These findings suggest that the composition and size of the particles is 




1.5. MEASURING HEATING EFFICIENCY OF MAGNETIC NANOPARTICLES 
 
One way of characterizing magnetic particle-polymer complexes is by calculating 
the power generated per mass of magnetic material. The power generated by a solution of 
MNPs with the application of an alternating magnetic field can be described as the 
volumetric power dissipation, P, in watts per unit volume,44 shown below. 
𝑷 =
𝝁𝟎𝝎𝟐𝝉𝑯𝟎𝟐𝝌𝟎
𝟐(𝟏+ 𝝎𝝉 𝟐) 
where 𝜇! is the permeability of free space (1.26×10-6 kg m s-2 A-2), 𝜔 is the 
frequency of the magnetic field, 𝜏  is the relaxation time, Η! is the magnetic field intensity, 
and 𝜒! is the magnetic susceptibility. 
Because not every MNPs system is identical, the heating efficiency of particles is 






where 𝐶 is the specific heat capacity of the media (e.g., 4.186 J g-1 °C-1), 𝑚!"#$%& 
is the mass of the sample, 𝑚!"#$  !"#$% is the mass of iron oxide determined magnetically, 
and 𝑑𝑇/𝑑𝑡 is the slope of the heating curve.  
To measure the SAR of a MNP solution, an alternating magnetic field system is 
utilized. These consist of a copper induction coil that wraps around the sample, capacitors 
to form a resonance circuit, and a power supply. The induction coil is wrapped around the 
sample holder that is temperature controlled by recirculating water, Figure 1.2. An 
example of a capacitance network, used by Ivkov et al., created an oscillation of ~153 
kHz and used a 0-25 kW generator to power it.49 The sample chamber’s magnetic field is 
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mapped with a magnetic probe to measure the field produced in the induction coil. An 
infrared thermocouple is used to monitor temperature change over time of the magnetic 
fluid.40,41,45,46,48,50-52 Studies show that higher heating rates are obtained by decreasing the 
polydispersity and “optimizing the size for a given set of conditions, most specifically the 
frequency of the AC-field.” 45 
 
Figure 1.2. General schematic of AC calorimeter that can be used to measure SAR. 
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Currently, there is one unit magnetic hyperthermia applicator in clinical use 
[MFH300F].53 This system uses an alternating magnetic field with a frequency of 100 
kHz and variable field strength of 0-18 kA m-1. To measure heating rate in situ, fiber 
optic thermocouples were surgically positioned into the prostate, urethra, rectum, 
perineum, scrotum and left ear and monitored with software. The temperature could be 
read at a constant field strength or even allow the researchers to adjust the field strength 
to reach any desired temperature.  
Though current MNPs systems used for magnetic hyperthermia studies are 
generally polydisperse in size, it is speculated that more monodispersed particles will 
create a more efficient therapeutic system.44 While some experimental protocols have 
been used to report the heating efficiencies of these materials like SAR, the field lacks a 
consistent and accepted manner to characterize the heating efficiency that can be 
reproduced throughout the community. For example, the SAR value reported by one 
instrument may be different than that reported for the same material by an instrument 
operating at a different field and frequency of the first measurement.  In addition the SAR 
value does not include specifics regarding “size, size distribution, shape and chemical 
composition of particles, frequency and amplitude of magnetic field”.46 General 
equations describe SAR as the heat capacity of the material multiplied by the change in 
temperature over some given time. M. Ma et al. described the equation that uses a mass 
weighted mean value of the heat capacity of the particles and solvent.48 Because the SAR 
value can be altered for the same sample by merely modifying the field frequency and 
strength, the intrinsic loss power (ILP) was developed to better compare between 
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experiments by adding field (𝐻)  and frequency   (𝑓)  to the equation, but only at 




While the ILP offers an alternative to reporting SAR, it does not resolve the issues 
related to difference in instrumentation.  For example, the ILP normalization is only 
effective in the linear region according to Eggemen et al.43 They found that the size, 
composition, and shape are not enough to predict the effects they have on heating in an 
alternating magnetic field. 
1.6. PARTICLE MODIFICATION 
 
Nanoparticle systems used for targeted drug delivery have historically been 
liposomes, polymer-drug conjugates, and micelles that deliver a drug encapsulated into 
the core of the nanoparticle. Liposomes are made up of a phospholipid bilayer that 
comprise of lipids that have a fatty hydrocarbon tail and a hydrophilic head group; these 
separate an aqueous internal compartment from an aqueous bulk. Micelles are comprised 
of a lipid monolayer that has a fatty core and a charged hydrophilic surface.  
Surface modification of nanoparticles is critical to improving stability, 
biocompatibility, and success in targeted magnetic hyperthermia, which is discussed later 
in this review. The nanoparticle complexes described here are a core-shell structure, in 
which iron oxide is the core and the shell is comprised of polymeric coatings. Examples 
of these core-shell complexes can be found in Table 1. MNPs have been modified with a 
variety of ligands using different synthetic routes. One commonly used method for 
surface coating is the physical adsorption of material onto the surface of the particle. 
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Another such method to coat MNP surfaces also involves covalently or electrostatically 
bonding a polymer to the particle surface. Electrostatically binding of a polymer to 
modify IONPs has been reported with different polymer ligands using end and side chain 
functional groups such as carboxylates,54 alcohols,55 amines,56 and phosphates.57,58 For 
example, dextran has been shown to adsorb to the surface of IONP to create a dispersible 
complex in a biological system.59 Dextran has been used to modify coprecipitation MNPs 
for biological systems currently used in MRI contrast agents.20 Unfortunately, some of 
these binding groups can be displaced by other anions such as phosphates and silicates.60 
Once in contact with biological fluids, however, this displacement of the polymer coating 
on the surface of the magnetic nanoparticles can lead to IONP instability and aggregate 
formation. The advantage of chemical adsorption over physical adsorption is strength of 
adhesion to the particle. The heat of adsorption is much higher for a chemical bond (-40 
to -1000 kJ/mol) than physical interaction (-10 to -40 kJ/mol) of a molecule onto a 
surface.61 A binding group that shows great promise for binding biologically inert ligands 
are catechol derived anchor groups.62-64 Gu et al. has demonstrated that oleic acid and 
oleic amine on the surface of magnetite can be displaced with dopamine derivatives that 
bind tightly to iron oxide surfaces.65 Amstad et al. used dopamine as an anchor for 






Table 1. Representative schematics of existing magnetic nanoparticle complexes 
Particle Complex Description 
 
Magnetic nanoparticle coated with hydrophilic polymer 
ligand7,57,67-69 
 
Multiple magnetic nanoparticles encapsulated in cross-
linked polymer matrix70,71 
 
Single magnetic nanoparticle with copolymer ligands; 
PEO/PLA, PEO/PGMA72,73 
 
Ligands with hydrophobic head and hydrophilic tail to 
encapsulate particle25,74 
 
Nobel metal coated magnetic nanoparticle31,35,36 
 
Controlled clustering of nanoparticles, and then coated 





Biologically inert polymers have been used to modify IONPs for magnetic 
hyperthermia, which is advantageous for controlling the particles size and functionality 
that permits multiple applications. Polyethylene glycol (PEG) is one such polymer being 
explored for use biological particle systems. Because of its solubility in water, low 
immunogenity, and fast renal clearance, PEG is ideal for biomedical applications.76 Many 
multifunctional PEG ligands have been synthesized, some of which are commercially 
available, for modifying MNPs.  
Block copolymers have been exploited for altering solubility and thermal 
properties for entrapment and controlled release of drugs, a concept also applied to the 
encapsulation of MNPs. Triblock copolymers of polyethylene glycol and polypropylene 
oxide (PPO), commonly known as a pluronic, have been used in multiple applications (i.e. 
detergency, emulsification and drug delivery systems).77 This amphiphilic polymer has 
been utilized to create a polymer shell that is biocompatible and can be modified for 
targeting purposes. Pluronics have also been studied for the use in temperature-controlled 
release of drugs; when the polymer is above its critical micelle temperature, the polymer 
collapses on itself to contain the drug. Once the MNPs are accumulated in the diseased 
tissue, the temperature is decreased to extend the ligands and release the drug.72,73 
Another polymer system of interest for the temperature-controlled release of drugs is 
random block copolymer composed of poly(N-isopropylacrylamide) (pNIPAAm) with 
hydrophilic monomers. These thermo-sensitive block copolymer have a lower critical 
solution temperature (LCST) in which the polymer, above the LCST converts to a coiled 
formation as opposed to extended chain formation.78 Meyer et al. have combined 
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PNIPAAm and PEG as a copolymer to encapsulate MNPs and drugs simultaneously. 
When these particles are subjected to an AC field, temperatures higher than LCST of the 
PNIAAm are achieved, causing the polymer to coil and force the encapsulated drug into 
the surrounding tumor.79 
1.7. SIZE AND SURFACE CHARGE EFFECTS ON STABILITY 
 
Designing a stable MNPs system requires a balance between repulsive and 
attractive forces within a colloidal system. According to a modified Derjaguin-Landau-
Verwey-Overbeek (DLVO) theory, shown in Figure 1, these forces include van der 
Waals, electrostatic repulsion, steric repulsion, and magnetic attraction forces that 
mediate the stability of an MNPs system.79 Magnetic interactions for superparamagnetic 
nanoparticles, ideally should be non-existent. Achieving a narrow size distribution of 
particles that have no net magnetic moment is difficult and will require an increase in the 
repulsion forces to decrease agglomeration due to magnetic interactions.80 
 
Figure 1.3. The interaction potential between magnetic nanoparticles can be determined 
by adding the potential energies of the particles as a function of their distance. 
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By calculating the potentials for the interaction between two particles in solution, 
it is possible to infer the effects of various parameters (i.e. core particle size, degree of 
coverage by stabilizing layer, molecular weight of the stabilizing polymer, solvent 
conditions, etc.). For example, the radius of the core of MNPs is critical for the colloidal 
stability of a system; indeed small portions (<1%) of the population of a polydisperse 
system may be responsible for agglomeration.67 
1.8. MOLECULAR WEIGHT AND SURFACE CHARGE EFFECTS ON STABILITY 
 
Surface modification, using methods described previously, alters the MNPs in 
order to: i) reduce the immune response of the body; ii) enable the homogeneous 
suspension of the nanoparticles in physiological solutions; and iii) provide a stabilizing 
layer that prevents particle agglomeration. For example, Ditsch et al. coated 7.5nm 
diameter (polydispersity of 0.26) magnetite nanoparticles with block copolymers of 
sodium styrene sulfonate, sodium vinyl sulfonate and acrylic acid.  It was discovered that 
at low molecular weights, e.g. <15 kDa, steric repulsion was not great enough such that 
particle clustering may occur. Steric repulsion was enhanced when the PEG molecular 
weight increased which resulted into a suspension of dispersed particles. However, if 
molecular weight is further increased, e.g. 30kDa, polymer chains begin to entangle and 
clustering would again occur in the system caused by entanglements of neighboring 
particles’ brushes and thus bring the particles together.75  
Both the molecular weight and the structure of the surfactant affect particle 
stability,81 particularly in copolymers with hydrophobic and hydrophilic blocks, like 
PEG-PPO block copolymers. PEG is a liner polyether comprised of a repeat unit of two 
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methylene groups and an oxygen, which gives it hydrophilic properties. PPO has a very 
similar structure, but has a branched methyl group off of the methylene groups in the 
chain that makes it hydrophobic.  The molecular weight necessary for minimum 
clustering will shift with a ratio change between the hydrophilic and hydrophobic 
segments in the polymer chain. If the hydrophilic segment is larger than the hydrophobic, 
an increase in the total molecular weight of polymer chains is required to minimize 
clustering.75 
When modifying nanoparticles with a polymer, the overall particle size can 
increase significantly, affecting the functionality of the system. Compared to the 
autonomous magnetic core, the magnetic field strength of coated IONPs decreases by a 
small percentage. For example, in the development of MRI contrast agents, Tong et al. 
used different molecular weight IONP polymer coatings to demonstrate diverse T2 
relaxivity. Using 5 and 14nm magnetite nanoparticles coated with PEG with molecular 
weights of 550, 750, 1000, 2000, and 5000 g mol-1, respectively, they found that the 
particle system with the highest T2  relaxivity–385 ± 39 s-1mM-1–was the 14 nm diameter 
particle with 1000 g mol-1 coating. However, the indeterminate relationship between 
polymer molecular weight and T2 relaxation rate suggests the necessity of additional 
study.82 
It should be noted that for each size of magnetite particle, a sufficient steric or 
electrostatic stabilizing layer is necessary to maintain good colloidal stability.67 
Electrostatic effects are a product of the surface chemistry83 of the particle as well as the 
medium in which it is dispersed84. Relying on electrostatic repulsion alone could be a 
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poor choice, as the high ionic strength of the body would result in weak colloidal stability.  
This insufficient repulsive energy is due to ionic screening of the electric double layer 
around the particle. Wiogo et al. completed size and zeta potential studies on magnetic 
nanoparticles with carboxylic acid on the surface in water, phosphate-buffered solution 
(PBS), and cell culture media (RPMI-1640) to show how the ionic nature of the body can 
cause suppression of the electrostatic double layer on a nanoparticle used for biomedical 
applications.85 They found that in water, the zeta potential was -32+/- 5 mV and there 
was no significant size change after 16hrs. The same particles in PBS and cell culture 
media showed a ~10 mV decrease in zeta potential and a shift in the size distribution to 
larger size agglomerates. 
1.9. IMPORTANCE OF POLYETHYLENE GLYCOL IN THERAPEUTICS 
 
Polyethylene glycol (PEG) has been a FDA approved for use in a variety of 
cosmetics, pharmaceuticals, and even an additive in food.86 Due to its structure, it shows 
low toxicity and has renal clearance, <30 kDa.87 One of the initial applications of PEG 
was to overcome issues had with modifying polypetides with liposomes for drug 
delivery.88 The first PEGylation, a term describing the modification of small molecules 
with PEG, was done by Abuchowski et al. in 1976. Their group covalently attached 
monomethoxy terminated PEG, 1900 and 5000 g mol-1, to bovine liver catalase and 
found that it enhanced the circulation time in the blood of mice with no negative immune 
response to the modified enzymes.89 PEGylation is not only limited to enzymes, but has 
also been used to modify proteins to give it desirable drug delivery properties. A study on 
PEG in solution with proteins of similar molecular weight has found that the interaction 
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of water molecules with the polymer increases the size, protecting the proteins from 
immediate renal clearance and enzyme degradation.90 
Taking advantage of the unique biological properties of PEG, it can be linked to 
therapeutic agents to improve solubility, increase circulation in the body and decrease 
toxicity that are inherit in many small molecule drugs, including antitumor agents.91. 
Unfortunately, linking therapeutic agents to monofunctional PEG is limited in its 
efficiency because it can only rely on passive targeting to deliver the drug. Passive 
targeting takes advantage of irregular vascular structures in tumors to deliver the drug. 
Adding active targeting agents to drug complexes is needed to improve delivery 
efficiency. Active targeting requires a compound that will bind to over-expressed 
receptors found in tumors.92 One example of an active targeting compound is folic acid; 
many epithelial cancer cells, ie. ovary, kidney, colon, and lung, over-express folate 
receptors that have a high affinity for folic acid.93 Synthesizing PEG that can carry a drug 
and target specific receptors was the next step in drug delivery. In 2007, a group from 
Rutgers University reported the modification of a bis-carboxyl PEG modified with 
doxorubicin and sialic acid that showed an increase in anticancer activity and 
bioavailability.94 Improvement of therapeutic efficiency by attaching a targeting and drug 
to PEG was a huge advancement, but is limited by the extremely low drug loading that is 
inherent with a chain that can have a maximum of two functionalities. This has brought 
about the advancement of branched and multi-armed PEGs to provide multiple functional 
groups to increase the loading of therapeutic agents.95 
 18 
The use of polymers for the advancement of drug delivery naturally progressed 
into the development of polymeric nanoparticles for the same application. Polymeric 
nanoparticles, made up of conjugated96 and amphiphilic block copolymers,97 provide a 
large surface area and increased functionality that can be conjugated with a variety of 
drugs and targeting moieties. 
1.10. “CLICK CHEMSTRY” 
 
In a review by Kolb et al., they describe the foundation of the approach to “click 
chemistry” is to join small units together using selective and modular ‘blocks’ that can 
work in small and large scale applications.98 Using “click chemistry” as the approach for 
combining two molecules together is ideal for optimizing drug development and 
conjugation.99Nucleophilic ring opening reactions, carbonyl chemistry, and cycloaddition 
are all examples of synthetic routes that are under the umbrella of “click chemistry,” as 
defined by Sharpless.98,100 
The reaction that is almost synonymous with “click chemistry” is the 1,3-dipolar 
cycloaddition of alkynes and azides yielding an triazole, developed by Huisgen.100 
Alkyne and azide functional groups are extremely stable in many synthetic conditions.101 
Unfortunately, the reaction requires heat and creates a product of 1,4 and 1,5 
regioisomers, making it difficult to purify.101 That was true until copper (I), created insitu 
using a reducing agent, was used to catalyze the reaction in water to yield 1,4-
disubstituted 1,2,3-triazoles (>95% yield), an example is shown in Figure 1.3.102 
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Figure 1.4. Schematic of a 1,3-dipolar cycloaddition of alkyne and azide yielding a 
triazole. 
The mild reaction conditions of the copper catalyzed reaction of an alkyne and 
azide make it an ideal synthetic route for attaching biomolecules to each other, also 
referred to as bioconjugation. The triazole linkers are ideal for bioconjugation because 
they are soluble and stable in water as well as the harsh biological environments.103 
Cowpea mosaic virus (CPMV), a scaffold commonly used for testing bioconjugations, 
was modified with an alkyne and was tagged with an azide modified fluorescein, with a 
100% efficiency.104 DNA bioconjugation can be quite difficult and inefficient because it 
requires aqueous conditions. Seo et al. was able to tag a strand of DNA, for sequencing 
studies, modified with an alkyne and with a fluorophore modified with an azide, with a 
product yield of 91%.105 
These same reactions can be used to synthesize more efficient and specialized 
bioconjugated polymers for drug targeting and delivery. One research group used treated 
PDMS (hydrophobic) modified with an azide on both ends to attach PEG (hydrophilic) 
modified with an alkyne to produce a block copolymer that was used to create polymeric 
vesicles to carry hydrophobic drugs.106 Cheng et al. synthesized a heterobifunctional PEG 
with an alcohol on one end and bromine on the other. The bromine terminus was then 
reacted with sodium azide, via a substitution reaction, to yield an azide terminus. Then 









arm PEG that provides three functionalities per macromolecule to increase drug 
loading.107 Nanoparticles have also been synthesized to have either an alkyne or azide 
surface that can be easily modified with targeting agents (ie. folate)108,109 and dyes(ie. 
fluorescein)110 equipped with their respective counter functionality. 111-113  
1.11. OVERVIEW 
 
The following chapters will discuss the synthesis of heterobifunctional PEO for 
stabilizing magnetic nanoparticles for biological therapeutic and diagnostic applications. 
It will begin with the synthesis of a library of heterobifunctional PEO that were 
synthesized by the anionic ring opening polymerization of ethylene oxide using a variety 
of initiators that can produces thiol, azide, amine, alcohol, vinyl, and trivinyl end groups. 
Chapter 2 will also include different end group modification techniques important for 
creating functionalities that can be utilized for different applications. Chapter 3 will 
involve modifying magnetic nanoparticles with specialized heterobifunctional PEO that 
was synthesized using techniques in Chapter 2. These materials have a surface that can be 
built upon with diagnostic dyes and targeting moieties for biological applications. 
Chapter 4 builds upon the same scaffold that was developed in Chapter 3, but utilizes 
multiple binding groups to enhance biological stability while still maintaining 
functionality. Finally, the document will conclude with a discussion on how the design of 
these particles is not limited to just magnetic hyperthermia for the treatment of cancer, 
but that these particles can be used as an alternative to antibiotics, imaging in biofilms 
and a probe for emerging medical diagnostics. 
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CHAPTER 2.SYNTHETIC TECHNIQUES USED TO PRODUCE 




Polyethylene oxide (PEO) oligomers have become a desirable material in 
pharmaceutical and biomedical applications. The inert backbone in PEO provides a 
water-soluble platform that can be easily modified and survive in harsh biological 
environments.88 Through various initiators and end group modifications, an assortment of 
heterobifunctional PEO can be synthesized and customized for any specialized 
application. This chapter discusses the synthesis and characterization of different 
heterobifunctional PEO for biological applications. 
2.2. INTRODUCTION 
 
Polyethylene glycol (PEG), also referred to as polyoxyethylene (POE) and 
polyethylene oxide (PEO), is a “linear or branched polyether often terminated with 
hydroxyl groups that are derived from neutralization of the terminal ether repeated unit in 
the chain.”114 PEG is generally used when describing lower molecular weight polyethers 
(<10000 g mol-1) and PEO describes higher molecular weights (>10000 g mol-1).115 The 
repeating units are relatively unreactive which allows for modification of the end groups 
without affecting the chain integrity. PEO is also soluble in water and many organic 
solvents, which allows for a variety of routes in chemical modification of its end 
groups.54 Because of its solubility in water and capability of modification, PEO is ideal 
for biomedical applications; it has low immunogenity, renal clearance in vivo, and is not 
biodegradable.76  
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Creating a facile method for synthesis of heterobifunctional polyethylene oxide 
(PEO) is important for the functionalization of nanoparticles, which requires a strong 
binding group and then still have an end group that can be easily tailored to give a 
specific functionality. This research is vital in the successful integration of a material into 
biological environments and have the functionality to complete a task, ie targeting a 
specific site or fluorescent imaging. Using different initiators and end group 
modifications, a variety of heterobifunctionality can be customized for any application. 
There are two ways of synthesizing heterobifunctional PEO. One method involves 
the partial derivatization of polyethylene glycol diols, Figure 2.1, and then statistically 
collecting the desired heterobifunctional oligomer. This method is time consuming and 
extremely inefficient giving very low yields. 
 
Figure 2.1. Partial derivatization of diols of polyethylene glycol to create 
heterobifunctionality. 
 
The second method to creating heterobifunctional PEO is to initiate the 
polymerization of ethylene oxide (EO) using a functional initiator and, once propagation 
is complete, terminate with functional group as shown in Figure 2.2.116-119 Creating 



















polydispersity.114 Because these reactions are living in nature, it is important to keep 
water out of the reaction to avoid the formation of PEO diols that can reduce the targeted 
molecular weight.76  
 
Figure 2.2. Anionic ring opening polymerization using an initiator with X functionality 
and then terminating with a functionality of Y. 
The hydroxyl terminus is a great platform for synthesizing complex 
heterobifunctional end groups. The ease of hydroxyl modification allows for the 
conjugation of biomolecules by first modify the end group with carboxylic acid and then 
subsequently creating a succinimidyl ether intermediate120 that can easily react with 
amines of many bioconjugates.121,122 The purpose of this chapter is to show different 
techniques used to synthesize specialized heterobifunctional PEO. A variety of anionic 
initiators and end group modifications that were used to create the desired 
heterobifunctionality are described in detail. 




Tetrahydrofuran (THF; B.D.H. ACS grade) was purified by reflux over sodium 
metal (Aldrich Chemistry; sodium lump in kerosene 99%) and benzophenone. 
Naphthalene (Aldrich Chemistry ≥99%) was purified by sublimation at 60 °C under 
vacuum. Bromophenol blue (Sigma Aldrich), hydrochloric acid (HCl; J.T. Baker, 1N 
volumetric solution), acetic acid (BDH, glacial ACS/USD/FCC), ethylene oxide (EO; 













Chemistry, 25% w/w solution in toluene), tetrabutylammonium azide (Aldrich 
Chemistry), dichloromethane (DCM; EMD Millipore Chemicals, HPLC grade), diethyl 
ether (DEE; Macron Chemicals), toluene (BDH), 3-chloropropyltrichlorosilane, (Gelest, 
Inc.), vinylmagnesium bromide solution (Aldrich Chemistry, 1.0M in THF), ammonium 
chloride (Fisher Scientific, Certified ACS, Crystalline), magnesium sulfate (Mallinckrodt 
Chemicals, anhydrous powder), sodium chloride (Fisher Scientific, Certified ACS, 
Crystalline), sodium iodide (Sigma Aldrich, ACS reagent, ≥99.5%), sodium bicarbonate 
(J.T. Baker, anhydrous powder), hexamethylphosphoramide (HMPA; Aldrich Chemistry, 
99%), acetone (Fisher Scientific, Certified ACS), (2-(tetrahydro-2H-pyran-2-
yloxy)ethanol (THP; Aldrich Chemistry, purum ≥98% (GC)), chloroform-D (CDCl3; 
D,99.8%, Cambridge Isotope Laboratories Inc.), potassium bis(trimethylsilyl)amide 
solution (1M THF, Aldrich), and tert-butyl mercaptan (Aldrich Chemistry, 99%), 4-
(dimethylamino) pyridine (DMAP; Fluka Analytical), N,N’-dicyclohexyl carbodiimide 
(DCC; Thermo Scientific), 1-((3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC; Alfa 
Aesar, 98%), N-hydroxysuccinimide (NHS; Acros Organics 98+%), propargyl bromide 
solution (80% in toluene; Fluka), sodium hydride (NaH; Aldrich), 
dimethylformamide(DMF; 99.8%, Extra Dry over molecular sieves; Sigma Aldrich), 
methanol (absolute ACS reagent grade; Ricca Chemical Company), methacryol chloride 
(Fluka Analytical, ≥97.0%, GC, Contains ~0.02% 2,6-di-tert-butyl-4-methylphenol as 
stabilizer), and Spectrum Spectra/Por® molecular porous membrane tubing, MWCO of 
1K, 12K-14K, and 50K g mol-1 was used as received. 
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2.3.2. Potassium naphthalenide preparation 
 
Potassium naphthalenide was prepared in the follow way for all reactions.57 To a 
250 mL Erlenmeyer flask, 20g of naphthalene was put under vacuum at 60 °C until all 
naphthalene was sublimed onto the inside walls of the flask. The sublimed naphthalene 
(14.1 g, 0.11 mol) was then charged to a flame dried, 250 mL round bottom flask 
containing a stir bar. After submitted to a heavy purge of nitrogen, 100 mL of THF was 
added via syringe. Once naphthalene was completely dissolved, 3.96 g (0.10 mol) of 
potassium were added. The reaction was mixed for 12 hours at room temperature in 
darkness. The concentration of the solution was determined by titration, using 1 M HCl 
solution and bromophenol blue as an indicator, observing a color change from a deep 
blue to yellow. 
2.3.3. Characterization Techniques 
 
NMR spectroscopy was conducted using a Jeol ECX-300. Polymer samples were 
prepared by dissolving 50mg in 1 mL of deuterated chloroform and transferred into a 
5mm economy, 7", NMR sample tube via glass pipet. Each sample was analyzed using 
64 scans for 1HNMR and 20000 scans for 13CNMR at 20 °C. The NMR was controlled 
by Delta NMR Processing and Control Software (v 4.3.6, Windows_NT). The spectra 
were analyzed with Delta NMR Processing and Control Software (v 5.0.1, Darwin-x86). 
Fourier transform infrared spectroscopy (FTIR) using a Nicolet 6700 FTIR 
spectrometer. Spectra were acquired using attenuated total reflectance (ATR) on a 
diamond plate in air at room temperature. The wavelength recorded was from 550-
4500cm-1. 
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High-resolution transmission electron microscopy (TEM) images were acquired at 
an accelerating voltage of 300 kV on a Hitachi H-9500. TEM samples were prepared by 
dropping diluted hexane solutions onto a copper grid with carbon film. The mean size 
was acquired by averaging the diameter of 181 particles using FoveaPro image analysis 
software. 
Photoluminescence (PL) spectra were collected using a Horiba Jobin-Yvon 
MicroHR spectrometer.  
Thermogravimetric analysis (TGA) was accomplished using a Hi-Res TGA 2950 
thermogravimetric analyzer from TA Instruments. Experiments were controlled via 
Thermal Advantage Instrument Control Software (v 1.3.0.205) and thermograms were 
analyzed using TA Universal Analysis 2000 (v 3.9A, build 3.9.0.9). All samples where 
run with TA Instruments' platinum sample pans, 100 µL. The particles were exposed to 
nitrogen for 20 minutes, followed by a ramp to 100 ℃ at a rate of 20 °C min-1, held 
isothermally for 60 minutes, and then ramped to 800℃ at a rate of 20  °C min-1. 
Dynamic Light Scattering (DLS) and Zeta Potential measurements were used to 
measure hydrodynamic diameter and surface charge of particles, respectively, using a 
Malvern Zetasizer Nano ZS (Model:ZEN3600). Measurements were controlled and 
analyzed with Dispersion Technology Software (DTS) (v. 5.10). Size measurements and 
zeta potential measurements for water-dispersed particles were done in a “Size & Zeta” 
folded capillary cell(DTS1060).  
Gel permeation chromatography (GPC) was accomplished using a Waters Breeze 
system equipped with a UV/VIS and RI detector. Detection was done by differential 
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refractometer at 33 °C. Chloroform was the mobile phase at 1 mL min-1 and the injection 
volume per sample was at 50µL using an autosampler. All standards were prepared at 0.5 
mg mL-1. All samples had concentrations of 1 mg mL-1 in chloroform and filtered with 
0.2 µm Teflon membrane filters. The column used was a Water Styragel HR column – 
5E(effective MW range 2K to 4E6). 
2.4. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




Ethylene oxide, 7.76 g (0.176 mol), was distilled into a 300 mL stainless steel 
Parr Reactor cooled to -40℃ using an acetone dry ice bath, followed by the addition of 
100 mL of THF.  In a separate 50 mL flame dried, round bottom flask with stir bar and 
under nitrogen purge, 0.7 mL (6.21mmol) of t-butyl mercaptan was dissolved in 5 mL of 
THF. Next, 4.14 mL of a potassium naphthalenide solution (1.35 M) was added via 
syringe and stirred for 15 minutes. A white precipitate formed to indicate the formation 
of thiolates. The initiator solution was then charged to the reactor via syringe, and 
followed by 50 mL of THF. The reactor was brought to room temperature and reacted for 
48 hours. Polymerization was terminated with 1.47 mL of 2.5 M acetic acid solution in 
THF. The reactor was then purged with nitrogen for 1hr. Solvent was removed by rotary 
evaporation, and the product was dissolved in 200 mL of chloroform. The solution was 
then washed with 150 mL of deionized water. The organic layer was then concentrated 
down and precipitated using cold DEE and the polymer was retrieved by filtration. The 
remaining polymer was dried in vacuum oven at 25 °C (yield: 6.38g). 1HNMR (300 MHz, 
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CDCl3, δ in ppm): 3.61 (m, (CH2-CH2-O)n), 2.54 (t, CH2-S-C-(CH3)3), 2.43 (s, CH2-CH2-
OH), 1.29 (s, -CH2-S-C-(CH3)3. 
2.4.2. Results and Discussion 
 
Polyethylene oxide is typically synthesized by nucleophilic attack on the 
methylene group using an anionic initiator. In this case, the anionic initiator was created 
using potassium naphthalenide and tert-butyl mercaptan, shown in Figure 2.3, the thiolate 
formation was confirmed by precipitation.118 After the initiator was added to the 
monomer solution, the reaction was preformed under room temperature at 40 psi. After 
48 hours, the change in pressure dropped about 7 psi, indicating that nearly all of the 
ethylene oxide has been consumed. Acetic acid was used to protonate and terminate the 
living polymer. The polymer solution was then washed with water to remove any acid 
and then precipitated multiple times to remove any unreacted initiator.  
 
Figure 2.3. Anionic ring opening polymerization of ethylene oxide using tert-butyl 
mercaptan 
 
End group characterization and molecular weight of the polymer was then 
analyzed using 1HNMR. As seen in the spectrum in Figure 2.2, the two hydrogens of the 
methylene group adjacent to the thiol were observed as a triplet at 2.71 ppm. The three 
methyl groups in the protected group of the thiol have a chemical shit at 1.29 ppm (9H). 












the backbone of polyethylene oxide. Comparing the relative integrations of the methylene 
and the protecting group of the tert-butyl mercaptan to the integration of the methylene 
groups in the polyethylene oxide, the number average molecular weight was calculated to 
be ~1690 g mol-1. The target molecular weight of 2500 g mol-1 was not met possibly due 
to sample preparation and polymerization execution. Although extreme caution was used 
to keep all reactants and glassware dry, oxygen may have been present which could cause 
premature chain termination, thus decreasing the overall molecular weight. There is also 
a good possibility that the reaction was not given sufficient time to propagate, leaving 
unreacted monomer. 
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2.5. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




Ethylene oxide, 9.12 g (0.207 mol), was distilled into 300 mL stainless steel Parr 
Reactor cooled to -40 °C using an acetone dry ice bath, followed by the addition of 100 
mL of THF.  In a separate 50 mL flame dried, round bottom flask with stir bar and under 
nitrogen purge, 0.22 mL (3.23 mmol) of allyl alcohol was dissolved in 10 mL of THF. 
Via syringe, 3.26 mL of potassium naphthalenide solution (0.9 M) was added and stirred 
for 10 minutes. The initiator solution was then charged to the reactor via syringe, and 
followed by 50 mL of THF. The reactor was brought to room temperature and reacted for 
36 hours. Polymerization was terminated with 1.30 mL of 2.5 M acetic acid solution in 
THF. The reactor was then purged with nitrogen for 1 hour. Solvent was then removed by 
rotary evaporation, and the product was dissolved in 200 mL of chloroform. The solution 
was then washed with 150 mL of deionized water. The organic layer was then 
concentrated down and precipitated using cold DEE and the polymer was retrieved by 
filtration. The remaining polymer was dried in vacuum oven at 25 °C (yield: 5.855 g). 
1HNMR (300 MHz, CDCl3, δ in ppm): 3.617 (m, (CH2-CH2-O)n), 5.219 (m, CH2=CH-
CH2-), 5.880(m, CH2=CH-CH2-), 4.00, (d, CH2=CH-CH2-), 2.611 (s, CH2-CH2-OH). 
2.5.2. Results and Discussion 
 
The synthesis of an allyl alcohol initiated PEO, shown in Figure 2.5,123 with a 
target molecular weight of 2400 g mol-1 was accomplished by first creating an alkoxide 
by putting it into solution with a slight deficiency of potassium naphthalenide. The 
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reaction was done under 57 psi at a temperature of 24 °C and after 3 days, the pressure 
dropped to 50 psi indicating the polymerization of ethylene oxide and yielded 5.8 g of 
PEO.  The allyl end can act as an intermediate that can be modified with an amine or 
carboxylic acid using thiolated compounds through radical addition.76 
 
Figure 2.5. Anionic ring opening polymerization of ethylene oxide using allyl alcohol as 
an initiator. 
Proton NMR was used to determine if the desired heterobifunctionality was 
accomplished. The hydrogens of the alkene were found at 5.88 (2H) and 5.23 ppm (1H). 
The adjacent methylene had a chemical shift of 4.00 ppm (2H) and the methylene shift of 
the PEO backbone was at 3.62 ppm (284H). The number average molecular weight was 
determined to be 3200 g mol-1 by comparing the integration of the chemical shifts of the 
alkene end group to the methylene hydrogen shifts of the PEO backbone. The number 
average molecular weight of the polymer was also determined by GPC, compared to PEO 













Figure 2.6. Anionic ring opening polymerization of ethylene oxide using allyl alcohol 
2.6. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




Using a modified procedure from Gervais et al.,117 ethylene oxide, 15.2 g (0.345 
mol), was distilled into 300 mL stainless steel Parr Reactor cooled to -40℃ using an 
acetone dry ice bath, followed by 100 mL of toluene. In a flamed dried 50 mL round 
bottom flask, 1.0 g (3.52 mmol) of tetrabutylammonium azide was dissolved in 15 mL of 
toluene and added to reactor. Triisobutylaluminum, 7.60 mL (7.04 mmol), was added via 
syringe and an increase in temperature was observed. The reactor was then brought to 
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for 1 hour to remove unreacted monomer. The solution was vacuum filtered and the 
solvent was then removed by rotary evaporation, and dissolved in 200 mL of toluene. The 
resulting solution was then heated to 50 °C for 1 hour and then cooled to room 
temperature to precipitate the polymer to remove any unreacted tetrabutylammonium 
azide. The toluene was then removed by rotary evaporation and the product was 
dissolved in DCM and precipitated with cold DEE. The remaining polymer, 6.825 g, was 
dried in a vacuum oven at 25℃ and characterized by 1HNMR. 
2.6.2. Results and Discussion 
 
Synthesis of a heterobifunctional PEO with an azide has been done using end 
group modification, usually through a mesylated hydroxyl group that can be substituted 
with sodium azide.123 Labbé et al. has done work on polymerizing oxiranes using 
tetrabutylammonium bromide and triisobutylaluminum.124 The bromine terminus allowed 
for substitution with sodium azide to produce an azido end group.125 This approach 
allowed for control of molecular weight and required fewer reactions to get desired 
functionality. Gervais et al. built upon the aforementioned work by using a 
tetrabutylammonium azide and triisobutylaluminum catalyst to directly polymerize 
ethylene oxide and propylene oxide with an azide.117. 
The direct synthesis of an azido-terminated PEO, Figure 2.7, was accomplished 
with coordination polymerization using a ratio 1:2 of tetrabutylammonium azide and 
triisobutylaluminum catalyst, respectively, to target a molecular weight of 6000 g mol-1.  
The reaction was done for 24 hours at room temperature, where a decrease in pressure of 
about 10 psi was observed. 
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Figure 2.7. Coordination ring opening polymerization using tetrabutylammonium azide 
and triisobutylaluminum catalyst. 
The molecular weight was determined by GPC, against polystyrene standards, to 
be 10188 g mol-1 with a PDI of 1.61. Proton and carbon NMR were used to confirm the 
azido-terminated PEO. The large peak at 3.64 ppm was the familiar methylene shift for 
PEO. Unfortunately, finding any indication of the presence of the azide was difficult to 
determine with 1HNMR, Figure 2.8. Via 13CNMR, Figure 2.9,the carbon from the 
methylene peak adjacent to the azide, has a chemical shift at 61.89 ppm. To make sure 
that the shift is not part of the noise of the spectrum, contact ATR was used to confirm 
the presence of an azide. In Figure 2.10, the characteristic antisymmetric stretch of the 
azide appears at 2100 cm-1 and the antisymmetric stretch of the ether in the polyethylene 















Figure 2.8. 1HNMR of anionic ring opening polymerization of ethylene oxide using 
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Figure 2.9. 13CNMR spectra of anionic ring opening polymerization of ethylene oxide 
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Figure 2.10. FTIR spectra of anionic ring opening polymerization of ethylene oxide 
using tetrabutylammonium azide and triisobutylaluminum catalyst. 
2.7. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




2.7.1.1 Synthesis of 3-chloropropyltrivinylsilane 
 
A flame dried, 500 mL round bottom flask equipped with a stir bar and purged 
with nitrogen was charged with 25 g (0.112 mol) of 3-chloropropyltrichlorosilane and 
brought to 0 °C using a sodium chloride ice bath. A 1 M solution in THF of 
vinylmagnesium bromide (353.81 mL, 0.336 mol) was slowly cannulated into the round 
bottom flask. The reaction was then brought to room temperature and reacted for 24 
hours. To purify, the solution was then diluted with DCM and washed with an aqueous 
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ammonium chloride solution followed by three washes with a sodium chloride solution. 
Magnesium sulfate was then added to the organic layer to remove any residual water and 
them vacuum filtered. The filtrate was then reduced down using vacuum filtration and the 
product was distilled at 100 °C at 0.8 torr. Yield (15.69g) 1HNMR (300 MHz, CDCl3, δ 
in ppm): 0.841 (m, Si-CH2-CH2-CH2-Cl), 1.825 (m, Si-CH2-CH2-CH2-Cl), 3.490 (m, Si-
CH2-CH2-CH2-Cl), 5.782-6.201 (m, (CH2=CH)3-Si-). 
2.7.1.2. Synthesis of 3-iodopropyltrivinylsilane 
 
A flame dried, 500ml round bottom flask equipped with a stir bar, condenser and 
purged with nitrogen was charged with 15.0 g (83.0 mmol) of 3-
chloropropyltrivinylsilane. Sodium iodide 24.88 g (166.0 mmol) was added to a 250 mL 
round bottom flask and dissolved in 160 mL of acetone. The sodium iodide solution was 
then syringed into the 500 mL flask and heated at 56 °C for 24 hours. The acetone was 
then removed under vacuum and the product was dissolved in 250ml of DCM and 
vacuum filtered to remove insoluble salt byproducts. The solvent was then removed by 
rotary evaporation and the product was distilled at 100 °C at 0.8 torr. Yield (11.65 g) 
1HNMR (300 MHz, CDCl3, δ in ppm): 0.824 (m, Si-CH2-CH2-CH2-I), 1.871 (m, Si-CH2-
CH2-CH2-I), 3.165 (m, Si-CH2-CH2-CH2-I), 5.721-6.106 (m, (CH2=CH)3-Si-). 
2.7.1.3. Synthesis of 3-hydroxypropyltrivinylsilane 
 
Hexamethylphosphoramide (HMPA) (50 mL) was added to a 250 mL flame dried 
round bottom flask equipped with a condenser, stir bar, and purge with nitrogen. Sodium 
bicarbonate (3.40 g, 40.4 mmol) was added, followed by 11.0 g (40.4 mmol) of 3-
iodopropyltrivinylsilane. Water (6.54 mL, 363.0 mmol) was then added via syringe and 
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stirred at 100 °C for 24 hours. 3-hydroxypropyltrivinylsilane was then extracted twice 
with chloroform and distilled at 90 °C at 0.8 torr to receive pure product. Yield (8.95 g) 
1HNMR (300 MHz, CDCl3, δ in ppm): 0.713 (m, Si-CH2-CH2-CH2-OH), 1.616 (m, Si-
CH2-CH2-CH2-OH), 3.590 (m, Si-CH2-CH2-CH2-OH), 5.700-6.198 (m, (CH2=CH)3-Si-). 
2.7.1.4. Anionic Ring Opening Polymerization of Ethylene Oxide using 3-
hydroxipropyltrivinylsilane 
 
Ethylene oxide, 9.27 g (0.210 mmol), was distilled into 300 mL stainless steel 
Parr Reactor cooled to -40 °C using an acetone dry ice bath, followed by 100 mL of 
THF.  In a separate 50 mL flame dried, round bottom flask with stir bar and under 
nitrogen purge, 0.56 g (3.33 mmol) of 3-hydroxypropyltrivinylsilane was dissolved in 10 
mL of THF. Via syringe, 3.31 mL of potassium naphthalenide solution (0.9 M) was 
added and stirred until solution turned from a cloudy yellow to pink. The initiator 
solution was then charged to the reactor via syringe, and followed by 50 mL of THF. The 
reactor was brought to room temperature and held for 24 hours. Polymerization was 
terminated with 1.32 mL of 2.5 M acetic acid solution in THF. The reactor was then 
purged with nitrogen for 1hr. Solvent was removed by rotary evaporation, and dissolved 
in 200 mL of chloroform. The solution was then washed with 150 mL of deionized water. 
The organic layer was then concentrated down and precipitated using cold DEE and the 
polymer was retrieved by filtration. The remaining polymer was dried in vacuum oven at 
25°C (yield: 7.970 g). 1HNMR (300 MHz, CDCl3, δ in ppm): 0.73 (m, Si-CH2-CH2-CH2-
I), 1.63 (m, Si-CH2-CH2-CH2-I), 3.41 (m, Si-CH2-CH2-CH2-I), 5.71-6.19 (m, 
(CH2=CH)3-Si-), 3.65 (m, (CH2-CH2-O)n). 
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2.7.2. Results and Discussion 
 
The polymer described in this section was synthesized to create a 
heterobifunctional PEO that has multiple functional groups at one end that could be 
modified with anchoring groups to increase the interaction with magnetic nanoparticles.54 
To create the tri-functional PEO, an initiator was synthesized with three vinyl groups and 
an alcohol that was utilized in creating the needed alkoxide to ring open ethylene oxide, 
Figure 2.11. 
 
Figure 2.11. I) Synthesis of 3-chloropropyltrivinylsilane (CPTVS), II) 3-





Si Cl Si I









 H2O, 100°C, 24hrs
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The first step in synthesizing the initiator involves the modification of 3-
chloropropyltrichlorosilane (CPTCS) with vinyl magnesium bromide via a Grignard 
reaction, Figure 2.11 (I).  Excess Grignard reagent was not used to limit the reaction with 
the 3-chloropropyl end group and ensure the reaction was mainly with the silyl chlorides. 
Using 1HNMR, the resonance peaks of the silyl vinyl groups appeared at 5.73 and 6.30 
ppm (9H). These shifts for the silyl vinyl groups are found further downfield than 
observed with the allyl-PEO-OH (Figure 2.6) due to the close proximity of the hydrogens 
in the trivinyl groups that has caused desheilding of the protons to occur. The methylene 
peaks of the 3-chloropropyl appeared at 3.49 (2H), 1.83 (2H), and 0.84 ppm (2H), shown 
in Figure 2.12.  
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Figure 2.12. 1HNMR spectrum of chloropropyltrivinylsilane 
The second step taken was to synthesize 3-iodopropyltrivinylsilane (3-IPTVS), 
which involved replacing the chloride with an iodide via an SN2 nucleophilic substitution, 
Figure 2.11 (II). Chloride is a much stronger nucleophile than iodide, making iodine a 
better leaving group. The substitution was confirmed by 1HNMR, Figure 2.13, by seeing 
a small shift in the resonance of the methylene peaks adjacent to the iodine at 3.17 (2H). 
The other methylene peaks were observed at 1.87 (2H) and 0.82 ppm (2H). The vinyl 
silyl shifts were observed at 5.27 and 6.11 ppm (9H), indicating the vinyl groups are still 
present following the reaction. There is a shift at 2.15 ppm due to some that was not 
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Figure 2.13. 1HNMR spectrum of iodopropyltrivinylsilane. 
The final step, Figure 2.11 (III), in the synthesis of the trivinyl initiator involves 
the transformation of the alkyl iodide to an alcohol via a SN2 reaction using a polar 
aprotic solvent, HMPA. Conversion to alcohol was confirmed with 1HNMR by observing 
a shift in the methylene peak from 3.17 ppm to 3.59 ppm. The chemical shifts were still 
visible at 6.20 and 5.70 ppm and the proton ratios matched the predicted; 9:2:2:2, Figure 
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Figure 2.14. 1HNMR spectrum of hydroxypropyltrivinylsilane. 
Once the initiator was synthesized and characterized, it was used in the anionic 
ring opening polymerization of ethylene oxide, shown in Figure 2.15. Using potassium 
naphthalenide, the HPTVS was transformed into an alkoxide that will attack and open up 
the ethylene oxide ring. The reaction was performed at room temperature at 40 psi for 24 
hours. The pressure decreased about 10 psi, indicating most of the ethylene oxide had 
been consumed in the reaction. 
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The resulting polymer was characterized by 1HNMR, Figure 2.16, showing 
chemical shifts from the vinyl groups at 6.19 and 5.71 ppm. The methylene shift of PEO 
was a 3.67 ppm and the methylene shifts close to the tri vinyl silyl group were at 3.41, 
1.63, and 0.71 ppm. Number average molecular weight was calculated by comparing the 
peak areas and was determined to be 6400 g mol-1. The number average molecular weight 
determined from GPC was 6300 g mol-1 with a PDI of 2.1. 
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2.8. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




Ethylene oxide, 13.3 g (0.302 mmol), was distilled into 300 mL stainless steel 
reactor cooled to -40℃ using an acetone dry ice bath, followed by 100 mL of THF.  In a 
separate 50 mL flame dried, round bottom flask with stir bar and under nitrogen purge, 
0.64 mL (4.72 mmol) of 2-(tetrahydro-2H-pyran-2-yloxy)ethanol was dissolved in 10 mL 
of THF. Via syringe, 4.75 mL of a potassium naphthalenide solution (0.9 M) was added 
and stirred for 10 minutes. The initiator solution was then charged to the reactor via 
syringe, and followed by 50 mL of THF. The reactor was brought to room temperature 
and stirred for 72 hours. The polymerization was terminated with 1.90 mL of a 2.5 M 
acetic acid solution in THF. The reactor was then purged with nitrogen for one hour to 
remove any unreacted monomer. The solvent was then removed by rotary evaporation, 
and the product was dissolved in 200 mL of chloroform. The polymer solution was then 
washed with 150 mL of deionized water. The organic layer was then concentrated down 
and precipitated using cold DEE and polymer was retrieved by filtration. The remaining 
polymer was dried in vacuum oven at 25 °C (yield: 12.20 g). 1HNMR (300 MHz, CDCl3, 
δ in ppm): THP: 1.475-1.812 (-CH-(CH2)3-CH2-), 3.852 (m, CH-(CH2)3-CH2-O-), 4.761 
(t, -O-CH-O-). PEO: 3.630 (m, -(CH2-CH2-O)n-). 
2.7.2. Results and Discussion 
 
When synthesizing heterobifunctional polymers, protecting groups are necessary 
to ensure only one end is functionalized without disturbing the other. Tetrahydropyranol 
(THP) is a common hydroxyl-protecting group that is stable under non acidic 
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conditions.127 It can be easily cleaved by using an acid to produce a hydroxyl terminus 
that can be modified further.119 2-(tetrahydro-2H-pyran-2-yloxy)ethanol was used as an 
anionic initiator to grow ethylene oxide, Figure 2.17. The reaction was performed at room 
temperature at 40 psi for 72 hours. The reaction was terminated after the pressure 
decreased about 10 psi, indicating all of the ethylene oxide has been used.  
 
Figure 2.17. Anionic ring opening polymerization of ethylene oxide using 2 
The polymer end group functionality and molecular weight was determined by 
1HNMR, Figure 2.18. The signals for the hydrogen in the THP protective group were 
observed at 4.76 (1H), 3.85 (2H) and 1.81-1.48 ppm (6H). The characteristic methylene 
peak of PEO was found at 3.63 ppm (328H). The number average molecular weight was 
calculated by comparing the ratio of the integration of the signals of the THP to the 
methylene signals of PEO; 2500 g mol-1. The GPC result, calculated from a series of PEO 
















Figure 2.18. 1HNMR spectrum of anionic ring opening polymerization of ethylene oxide 
using 2-(tetrahydro-2H-pyran-2-yloxy)ethanoxide 
2.9. ANIONIC RING OPENING POLYMERIZATION OF ETHYLENE OXIDE 




Ethylene oxide, 9.03 g (0.205 mol), was distilled into 300 mL stainless steel Parr 
Reactor cooled to -40℃ using an acetone dry ice bath, followed by 100 mL of THF.  At  
-35 °C, 1.80 mL (8.26 mmol) of potassium bis(trimethylsilyl)amide solution was charge 
to the reactor followed by 10 mL of THF. The reactor was brought to room temperature 
and reacted for 36 hours. The reactor was then purged with nitrogen for 1 hour. Solvent 





























X : parts per Million : 1H
























chloroform. The solution was then filtered and the filtrate was then concentrated down 
and precipitated using cold DEE and polymer was retrieved by filtration. The remaining 
polymer was dried in vacuum oven at 25 °C (yield: 7.74 g). Removal of the trimethylsilyl 
groups was accomplished by dissolving the polymer in methanol and then slowly adding 
20 drops of 1N HCl and stirred for 24 hours at room temperature. The polymer was 
precipitated with DEE and polymer was collected by filtration and dried in a vacuum 
oven at 25 °C. 1HNMR (300 MHz, CDCl3, δ in ppm): 2.81 (t, NH2-CH2-), 2.754 (s, NH2-
CH2-), 3.635 (m, -(CH2-CH2-O)n. 
2.9.2. Results and Discussion 
 
Potassium bis(trimethylsilyl)amide is a commercially available compound that 
can be used as an initiator to polymerize ethylene oxide with a primary amine on one end 
and a hydroxyl group on the other after acid treatment, Figure 2.19.128 The 
polymerization was done at room temperature for 36 hours at 40 psi and was terminated 
when the pressure in the reaction vessel dropped 7 psi. After purification via precipitation, 
the collected polymer was characterized with 1HNMR and GPC to confirm end groups 
and determine molecular weight. 
 

















Figure 2.20 shows the broad primary amine signal and the adjacent methylene 
triplet signal overlap at 2.81 and 2.75 ppm respectively. The methylene signal was 
observed at 3.64, confirming polyethylene oxide was formed. The molecular weight was 
determined to be 4978 g mol-1 by comparing the ratio of the signal areas from the primary 
amine end group and the methylene shifts of PEO. Using polystyrene standards, GPC 
was used to determine the molecular weight to be 19776 g mol-1 with a PDI of 4.724.  
 
Figure 2.20. 1HNMR spectrum of the anionic ring opening polymerization of ethylene 
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2.10. CREATING HETEROBIFUNCTIONALITY THROUGH END GROUP 
MODIFICATION 
 
This section describes multiple methods used to create a desired functionality 
through the modification of an alcohol terminus. These synthetic techniques will prove 
useful in creating a variety of heterobifunctional polymers for almost any application. 




THP-PEO-OH  used in this modification was synthesized as described in section 
2.7. THP-PEO-OH (2 g, 0.627 mmol), succinic anhydride (0.105 g, 1.05 mmol), and 
DMAP (0.009g, 0.07 mmol) was added to a flame dried 50 mL flask equipped with a stir 
bar and dissolved in 20 mL of anhydrous THF. The flask was capped and purged with 
nitrogen. The reaction was done at room temperature for 12 hours and then precipitated 
with cold DEE. The collected polymer was then dissolved in chloroform and precipitated 
again with cold DEE, this precipitation was repeated, and the polymer collected was 
dried in a vacuum with no heat. (Yield 1.89 g) 1HNMR (300 MHz, CDCl3, δ in ppm): 























The esterification of the alcohol terminus with succinic anhydride, shown in 
Figure 2.21, is a common reaction that can be a very useful intermediate for synthesizing 
different heterobifunctional polymers129 as well as react with certain proteins.120 The end 
group functionalization was confirmed by 1HNMR, showing characteristic shift at 3.61 
ppm (2H) indicating ester linkage of the PEO to the succinic anhydride. The shift of the 
hydrogen of the two methylene groups located between the carbonyl groups of the 
succinic anhydride were found at 3.87 ppm (4H).  
 




The polymer used in this section was modified with a carboxylic acid using the 
method described in section 2.9.3. PEO-COOH (1.8g , 0.5 5mmol) was added to a flame 
dried flask equipped with a stir bar, along with NHS (0.063 g, 0.55 mmol) and DCC 
(0.141 g, 0.684 mmol) and dissolved in anhydrous THF. The flask was sealed and was 
reacted for 8 hours at room temperature under a nitrogen head.  
The reaction was then vacuum filtered to remove any insoluble N,N’-
dicyclohexylurea and then precipitated with cold DEE and the white precipitant was 
collected. The white precipitant was then dissolved in chloroform and precipitated with 
cold DEE two more times. The white precipitate was collected and dried under vacuum. 
(Yield 1.55 g) 1HNMR (300 MHz, CDCl3, δ in ppm): 2.804 (m,-OOC-CH2-CH2-COO-),  
2.690 (s,-CH2-CH2- of NHS), 3.631 (m, -(CH2-CH2-O)n). 
NitroDOPA, a catechol amine, is a desirable end group for many polymers 
because of its strong binding affinity to metal oxides.130. The PEO was now equipped 
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with an end group that would easily react with amines, Figure 2.22. This was taken 
advantage of by reacting it with the amine of nitroDOPA, shown in Figure 2.23. The 
resulting polymer was then precipitated with cold DEE to remove the byproduct of NHS. 
The precipitate was then dissolved in chloroform and vacuum filtered to remove any 
unreacted nitroDOPA. The filtrate was then precipitated with cold DEE and the resulting 
polymer was collected and stored in chloroform. 1HNMR (300 MHz, CDCl3), δ (ppm): 
3.64 (m, CH2-CH2-O), NitroDOPA: 6.12 and 6.90 (s, CH in ring). 
2.10.2.2. Results and Discussion 
 
 
Figure 2.22. End group modification of THP-PEO-COOH with NHS intermediate. 
NHS is commonly used as an intermediate to react with primary amines.120,131 It is 
also a popular synthetic technique used in linking bioconjugates to polymers.132-134 A 
PEO previously modified with a carboxylic acid was activated with NHS in preparation 
to react with the amine of nitroDOPA, Figure 2.22. The reaction was performed in 
anhydrous THF for 12 hours with DCC. Precipitation of insoluble N,N’dicyclohexylurea 
indicated the reaction took place and it was removed by filtration. 1HNMR was used to 
confirm NHS-ester linkage. The methylene shift of the NHS end group was indicated by 






















Figure 2.23. End group modification of THP-PEO-NHS with nitroDOPA. 
Once the PEO-NHS intermediate (0.2 g, 0.059 mmol) was synthesized and 
characterized, it was then reacted with nitroDOPA (0.017 g, 0.071 mmol), a catechol 
amine, in anhydrous DMF for 12 hours, Figure 2.23. The reaction was purified by 
precipitation with DEE. It was then dissolved in chloroform and the filtered to remove 
any unreacted nitroDOPA that is insoluble. The modification was confirmed by 1HNMR 
with the appearance of shifts at 6.05 and 6.90 ppm, which are the proton resonance of the 
benzene ring of the nitroDOPA. 




A THP-PEO-OH, synthesized as describe in section 2.7, was used and was 
modified with an alkyne, shown in Figure 2.24, using the following procedure. THP-
PEO-OH (1.5 g, 0.35 mmol) and sodium hydride (0.03 g, 1.3 mmol) were charged to a 
flame dried round bottom flask equipped with a stir bar and dissolved in 40 mL of THF. 
The reaction was brought to 0 °C using a salt ice bath and 120 µL of propargyl bromide 






























bromide was added, the reaction was stirred for another 30 minutes at 0 °C and then 
removed from ice bath to warm to room temperature and react for 24 hours. The resulting 
polymer was precipitated with cold DEE three times and solid was collected and dried 
under vacuum. The polymer was then dissolved in 20 mL of methanol and 20 drops of 
one molar HCl solution was slowly added. The reaction was stirred for 24 hours at room 
temperature to remove the protecting group. The polymer was the precipitated with cold 
DEE. The collected polymer was then dissolved in chloroform and precipitated again 
with cold DEE. The resulting solid was collected and dried under vacuum. Yield: 0.91 g. 
1HNMR (300 MHz, CDCl3, δ in ppm): 2.43 (m, CH≡C-CH2-), 4.19 (m, CH≡C-CH2-), 
3.65 (m, -(CH2-CH2-O)n). 
2.10.3.2. Results and Discussion 
 
 
Figure 2.24. End group modification of THP-PEO-OH with probargyl bromide to give 
alkyne functionality. 
Modification of a hydroxyl-terminated PEO with an alkyne group was completed 
using a substitution reaction with propargyl bromide, shown in Figure 2.22. The 
functionalization of PEO with an alkyne will allow for further derivation with azide-
functionalized molecules via a 1,3 dipolar cycloaddition between the two functionalities 
to form a triazole linkage, which is a reaction that is synonymous with “click chemistry.” 
119,135 The reaction took place under room temperature conditions in anhydrous THF for 
24 hours. Sodium hydride was used to catalyze the SN2 reaction, producing an ether 










confirmed the modification with an alkyne. The chemical shifts for the single proton of 
the on the alkyne was observed at 2.43 ppm (1H) and the methylene peak two carbons 
over showed proton resonance at 4.19 ppm (2H). 




A (TMS)2-N-PEO-OH, was synthesized as describe in section 2.8 was used and 
was modified with an alkyne using the following procedure. (TMS)2-N-PEO-OH (1.0 g, 
0.2 mmol) and sodium hydride (0.03 g, 0.8 mmol) were charged to a flame dried round 
bottom flask equipped with a stir bar and dissolved in 40 mL of THF. The reaction was 
brought to 0 °C using a salt ice bath and 80 µL of methacryloyl chloride solution (0.8 
mmol) was slowly added over 30 minutes at 0 °C. Once all the methacryloyl chloride was 
added, the reaction was stirred for another 30 minutes at 0 °C and then removed from ice 
bath to warm to room temperature and react for 24 hours. The polymer was then 
dissolved in 20 mL of methanol and 20 drops of 1M HCl solution was slowly added. The 
reaction was stirred for 24 hours at room temperature to remove the TMS protecting 
groups. The polymer was the precipitated with cold DEE. The collected polymer was 
then dissolved in chloroform and precipitated again with cold DEE. The resulting solid 
was collected and dried under vacuum. Yield: 0.711 g. 1HNMR (300 MHz, CDCl3, δ in 
ppm): 6.13 and 5.57(t, CH2=C(CH3)-CH2-), 4.19 (t, -C(=O)-O-CH2-), 3.64 (m, -(CH2-




2.10.4.2. Results and Discussion 
 
 
Figure 2.25. End group modification of PEO-OH with methacrylol chloride. 
Hydroxyl terminated PEO was modified with methacrylol chloride using a SN2 
reaction, catalyzed with NaH. The polymer was characterized with 1HNMR and 
modification was easily confirmed by the appearance of shifts at 6.13 and 5.57 ppm(2H) 
for the hydrogen of the terminal vinyl group. The methyl group on the methacrylate end 
group appeared at 1.95 ppm and the methylene hydrogens of the ethylene oxide repeat 
unit with a multiplet at 3.64 ppm. PEO with a methacrylate end group can be very useful 
in creating star graft copolymers,136 drug modification using thiol-ene chemistry,103 and 
crosslinking of magnetic nanoparticles to increase magnetic response.137 
2.11. CONCLUSION 
 
Polyethylene oxide is very versatile polymer that can be used in a variety of 
applications. Developing skills of polymer synthesis and endgroup modification will 
allow for an arsenal of heterobifunctional polyethers that can be used for surface coatings 
that will provide functionality. These synthetic techniques are not limited to PEO oxide; 
they are well-studied techniques that can be applied to other polymer systems. The 
polymers described in this chapter were synthesized and modified with relative ease and 






















CHAPTER 3. SYNTHESIS AND CHARACTERIZATION OF 
HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE) PLATFORM FOR 




Contemporary magnetic nanoparticle composites are individually designed for a 
specific application: magnetic hyperthermia, cell separation, and MRI contrasts agents. 
The work that is described here involves the synthesis of a single magnetic nanoparticle 
composite with a surface that can be customized for any application. The discussion of 
the syntheses and characterization of a heterobifunctional polyethylene oxide (PEO) 
using nitroDOPA as a robust anchoring group on one end and an alkyne as the reactive 
surface for additional application specific modification. The potential for these scaffolds 
allows them to be utilized in a variety of research fields because of the efficiency and 
ease of modification that is inherit in the Huisgen 1,3-dipolar cycloaddition between an 
azide and alkyne, commonly known as “click chemistry.” Synthesis of this specialized 
polymer-particle complex exhibited biological stability and modifiable surface by 
attaching a fluorescent dye using “click chemistry.” 
3.2. INTRODUCTION 
 
Magnetic nanoparticles are ideal materials for bioimaging,138 therapy and 
delivery.139 These blossoming technologies are not possible without designing and 
synthesizing specialized materials to stabilize the magnetic nanoparticles in biological 
environments. For the stabilizing layer, the material must be biologically inert and have 
sufficient steric hindrance to provide a long circulation time in the body.140 To increase 
efficiency of materials used in biological imaging, therapy and delivery, the surface must 
 60 
be enhanced with biological targeting and labeling molecules to both increase the 
concentration of the particles in the desired location of the body and to monitor the 
particles’ fate.141  
When designing polymer-particle systems for biomedical applications, it is very 
important to have a robust anchor to ensure particle stability in protein rich environments. 
Some traditional anchor groups studied for iron oxide nanoparticles are carboxylic 
acids,54 alcohols,55 amines,56 silanes,142 ammonium,143 and phosphates.58 Another 
molecule being heavily researched as a robust anchor for iron oxide nanoparticles are 
catechols, which were inspired from a protein adhesive featured in mussels.144 Catechol-
derived ligands have been found to displace other binding groups on the surface of iron 
oxide145 as well as create stable particles in physiological conditions.66,146 The catechol 
groups used for anchoring to iron oxide are generally found in dopamine-derived 
molecules that can be attached to polymers through the terminal amine using a common 
crosslinking chemistry that utilizes N-hydroxysuccinimide (NHS) esters to activate 
carboxylic acid for reactions with amines.131 
In this chapter, a heterobifunctional polyethylene oxide (PEO) ligand was 
synthesized for the stabilization and functionalization of magnetic nanoparticles. 
Utilizing ordinary chemistry, a synthetic route was developed that produces a 
heterobifunctional PEO ligand with a robust anchoring group and a reactive surface. PEO 
is ideal for theranostic systems, term used to describe particles that can be used for both 
therapeutic and diagnostic applications, not only because of how inert the backbone is to 
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protein absorption,147 but this relatively unreactive polymer chain allows for modification 
of the end groups with relative ease.114 
3.3. EXPERIMENTAL 
 
3.3.1. Synthesis of nitroDOPA 
 
In a 50 mL round bottom flask, equipped with a stir bar, 30 mL of DI water was 
cooled in a brine salt bath to 0 ºC before adding sodium nitrite (1.52 g, 17.88 mmol) and 
L-3,4-dihydroxyphenylalanine (L-DOPA) was added (1.97 g, 9.99 mmol) and allowed to 
cooled. While stirring, 0.92 mL (90.23 mmol) of sulfuric acid was added dropwise to 
form an orange precipitate. Once all of the acid was added, the solution was stirred 
overnight. The product was collected by vacuum filtration, washed with methanol, and 
dried in a vacuum oven (30% yield).  
1HNMR (300 MHz, DMSO-D6), δ (ppm): 7.46 and 6.84 ppm (s, CH, ring, 
nitroDOPA), 3.54-3.49 ppm (t, J=15, -CH2-CH-N-), 3.31-2.98 ppm (m, -CH2-CH-N-), 
13CNMR (300 MHz, DMSO-D6) δ (ppm): 170.7, 153.4, 145.2, 139.2, 126.9, 119.9, 112.6, 
54.8, 40.0, 35.4. 
3.3.2. Synthesis of THP-PEO-OH 
 
 
Figure 3.1. Anionic ring opening polymerization of ethylene oxide using THP initiator. 
EO (13.3g, 0.30 mol) was distilled into 300 mL stainless steel reactor cooled to -










flame dried, round bottom flask with stir bar and under nitrogen purge, dissolved 2-
(tetrahydro-2H-pyran-2-yloxy)ethanol (0.65 mL, 4.72 mmol) in 10 mL of THF. Via 
syringe, 4.75 mL of potassium naphthalenide (0.9 M) was added and stirred for 10 
minutes. The initiator solution was then charged to the reactor via syringe, and followed 
by 50ml of THF. The reactor was brought to room temperature and held for 72 hours. 
Polymerization was terminated with 1.90 mL of 2.5 M acetic acid solution in THF. The 
reactor was then purged with nitrogen for 1hr. Solvent was removed by rotary 
evaporation, and then dissolved in 200 mL of chloroform. The solution was then washed 
with 150 mL of deionized water. The organic layer was then concentrated down and 
precipitated using cold DEE and polymer was retrieved by filtration. The remaining 
polymer was dried in vacuum oven at 25 °C and characterized by 1HNMR. Molecular 
weight was calculated by comparing the ratio of the area of THP to the polyethylene 
backbone and was found to have a molecular weight of 6300 g mol-1. 
1HNMR (300 MHz, CDCl3), δ (ppm): THP: 1.47-1.88 (m, CH-(CH2)3-CH2), 3.87 
(m, CH-(CH2)3-CH2-O), 4.61 (t, J=6.9, O-CH-O). PEO: 3.64 (m, CH2-CH2-O). 
3.3.3. Synthesis of THP-PEO-Alkyne 
 
 
Figure 3.2. End group modifcation of THP-PEO-OH with propargyl bromide. 
A 100ml round bottom flask was equipped with a stir bar and flame dried. The 











g, 1.0 mmol) and finally sealed and purged with nitrogen. THF (20 mL) was then added 
via syringe to dissolve reactants and was brought to 0 °C using a NaCl ice bath for 30 
minutes. Propargyl bromide (0.09 mL, 1.0 mmol) was added slowly via syringe over 30 
minutes, followed by 30 minutes of stirring at 0 °C. The reaction was removed from ice 
bath and warmed to room temperature and stirred for 24 hours. The final solution was 
filtered via vacuum filtration and subsequently precipitated twice with DEE. The final 
product was dried in vacuum overnight. 
1HNMR (300 MHz, CDCl3), δ (ppm): 1.47-1.88 (m, CH-(CH2)3-CH2), 4.63-4.61 
(t, O-CH-O), 3.64 (m, CH2-CH2-O), 2.43-2.44 (t, -O-CH2-C≡CH), 4.198-4.190 (d, -O-
CH2-C≡CH) 
3.3.4. Deprotection of THP-PEO-Alkyne 
 
 
Figure 3.3. Cleavage of tetrahydropyranol to yield alkyne-PEO-OH 
THP-PEO-alkyne (0.8 g, 0.17 mmol) was dissolved in 10 mL of methanol. Three 
drops of 1 M HCl solution were added and the solution and stirred for 4 hours. The 
product was recovered by crashing into DEE, and solid was collected using vacuum 
filtration. The product was characterized by 1HNMR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.42-2.44 (t, -O-









3.3.5. Synthesis of Alkyne-PEO-COOH  
 
 
Figure 3.4. Modification of alcohol terminus with carboxylic acid using succinic 
anhydride. 
A round bottom flask equipped with a stir bar was flame dried and charged with 
alkyne-PEO-OH (0.8 g, 0.17 mmol) and placed in a vacuum oven for 30 minutes at 80 °C. 
SA (0.03 g, 0.27 mmol) and DMAP (0.002 g, 0.02 mmol) were added to round bottom 
flask and then it was purged with nitrogen. Finally, anhydrous THF (20 mL) was then 
added to the flask via syringe and stirred for 8 hours. The reaction was then precipitated 
with cold DEE. The precipitant was collected and dissolved in 5 mL of DCM and 
precipitated again with cold DEE (2X). The final precipitant was collected and dried in a 
vacuum oven overnight. The polymer was characterized using 1HNMR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.58 (m,-CH2-CH2-
C(O)-O-), 2.42-2.44 (t,-O-CH2-C≡CH), 4.187-4.195 (d, -O-CH2-C≡CH) 
3.3.6. Synthesis of Alkyne-PEO-NHS 
 
 
Figure 3.5. PEO-alkyne modified with NHS intermediate 
In a flame dried, 25 mL round bottom flask with a stir bar, alkyne-PEO-COOH 
(0.73 g, 0.15 mmol), NHS (0.02 g, 0.18 mmol), and DCC (0.04 g, 0.18 mmol) were 

































reacted for 4 hours at room temperature. The solution was then vacuum filtered to 
remove any dicyclohexylurea that precipitated during the reaction. Using rotary 
evaporation, the THF was removed from the filtrate and the product was dissolved in 5 
mL of DCM and precipitated with DEE (2x). The precipitate was collected and dried in a 
vacuum oven (83% yield). The product was characterized by 1HNMR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 4.22 (m, -CH2-O-
C(O)-), 2.72 (m,-CH2-CH2-C(O)-O-), 2.42-2.44 (t, -O-CH2-C≡CH), 4.19-4.20 (d, -O-
CH2-C≡CH), 2.80 (s,-C(O)-CH2-CH2-C(O)-). 
3.3.7. Synthesis of Alkyne-PEO-NitroDOPA 
 
 
Figure 3.6. Modification of PEO with nitroDOPA 
A flame dried, 50 mL Erlenmeyer flask equipped with a stir bar was charged with 
alkyne-PEO-NHS (0.69 g, 0.14 mmol) and nitroDOPA (0.04 g, 0.17 mmol), capped, and 
purged with nitrogen. Next, 10 mL of DMSO was added via syringe and stirred for 4 
hours at room temperature. Finally, the resulting reaction was precipitated with DEE and 
the product was dissolved in chloroform and filtered to remove any excess nitroDOPA. 
The final polymer was precipitated with cold DEE, collected, and dried in vacuum oven 


























1HNMR (300 MHz, CDCl3), δ (ppm): 3.64 (m, CH2-CH2-O), 2.72 (m, -CH2-CH2-
C(O)-O-), 2.42 (s, -O-CH2-C≡CH), 4.20 (d, -O-CH2-C≡CH). NitroDOPA: 6.12 and 6.70 
(s, CH in ring). 
3.3.8. Synthesis of magnetite nanoparticles 
 
The 7.2 nm magnetic nanoparticles, synthesized using thermal decomposition of 
iron(III) acetylacetonate (2 mmol), 1,2-hexadecanediol (10 mmol), oleylamine (4 mmol), 
benzyl ether (20 mL), and 6 nm iron oxide seeds were added and stirred under a nitrogen 
flow and brought to 200 °C for one hour to remove any moisture. Finally the reaction was 
brought to reflux for 30 minutes under a nitrogen head. The particles were purified by 
precipitation of ethanol and characterized using TEM and DLS. 
3.3.9. Modification of magnetite nanoparticles 
 
The magnetic nanoparticles were modified by first dissolving alkyne-PEO-
nitroDOPA (200 mg, 0.04 mmol) into 10ml of chloroform followed by the slow addition 
of 1ml (2 mg of Fe3O4 mL-1) of magnetic nanoparticles, which were also dispersed in 
chloroform, while sonicating over 30 minutes. The solution was allowed to stir overnight. 
The particles were then purified by precipitation with hexane, centrifuged to separate 
particles from solvent. They were then dispersed in ethanol and subsequently precipitated 
using hexane and separated via centrifugation to collect particles. Finally, the particles 




3.3.10. Functionalization of alkyne-PEO-nitroDOPA coated magnetic nanoparticles with 
azido-functionalized dyes 
 
Modification with azido-fluorescein dye 
 
To 10ml of DI water, 0.2 mL of modified particles (0.7 mg of modified particles 
mL-1) was added. The azido-fluorescein dye (0.003 mmol) was added to solution 
followed by CuSO4 (0.013 mmol) and sodium ascorbate (0.003 mmol). The reaction was 
then covered with foil and stirred at 32 °C for 24 hours. The particles were then removed 
from heat and dialyzed for 2 days against DI water. 
Modification with azido-fluorescein and carbazole dye 
 
To 50ml of THF, 1ml of modified particles (4.11mg/mL) was added. Azido-
fluorescein (0.67mg, 0.001mmol) and azido-carbazole (0.21mg, 0.001mmol) was then 
added to the solution. While stirring, 121 µL aqueous solution of CuSO4 (15mM) and 
54µL aqueous of sodium ascorbate (11.1mM) was added to the solution and reacted for 
24 hours at 32 °C. The particles were removed for heat and the THF was then removed 
by rotary evaporation. The particles were then dispersed in 5ml of DI water and dialyzed 
for 3 days against DI water. 
3.4. RESULTS AND DISCUSSION 
 
The synthetic design begins with the anionic ring opening polymerization of 
ethylene oxide using 2-(tetrahydro-2H-pyran-2-yloxy)ethanol (THP) as the alkoxide 
initiator (Figure 3.1), based on previous work by Hiki et al.119 This synthetic approach is 
ideal for creating narrow molecular weights and is more efficient than partial derivation 
of diols.114 Beginning with one protected end group allows for precise and efficient 
modification for desired heterobifunctionality. With one of the end groups protected, the 
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free alcohol was modified with propargyl bromide via a substitution reaction to produce 
the alkyne functionality needed (Figure 3.2). After cleaving the tetrahydropyranol 
protecting group with an acid (Figure 3.3), the other alcohol was free to be modified. 
Through a series of reactions, which included modification with succinic anhydride (SA) 
(Figure 3.4) and the N-hydroxysuccinimide (NHS) (Figure 3.5), the polymer was primed 
to be modified through the amine of nitroDOPA (Figure 3.6). 
 NitroDOPA was synthesized using a procedure by Yang et al148 and used as our 
anchoring system based on a study by Amsted et al that compared the stability of a 
variety of catechol complexes in which they found nitroDOPA having one of the higher 
binding affinities.62 Using 13CNMR (Figure 3.7) and FT-IR (Figure 3.8), nitration of the 
DOPA was confirmed by the symmetric and asymmetric stretching peaks at 1330 and 
1532 cm-1, respectively. 
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Figure 3.8. Interferogram of  DOPA (top) and nitroDOPA (bottom). Symmetric and 




Figure 3.9. TEM micrograph of iron oxide nanoparticles synthesized via thermal 
decomposition with a mean size of 7.2nm ± 0.9. 
Monodispersed iron oxide nanoparticles in hexane were synthesized using a 
method from Sun et al.149 The particles core size was found to be 7.2 nm ± 0.9 nm in 
diameter by TEM (Figure 3.9) and the hydrodynamic diameter was found to be 29.2 ± 
17.1 nm (Table 3.1). The particles were then modified via ligand exchange using PEO 
modified with nitroDOPA. Sonication and stirring overnight aided in the replacement of 
the oleylamine, a hydrophobic ligand, with the polymer ligand in chloroform. The 
particles were then precipitated with an anti-solvent and finally dispersed into DI water. 
PEO with a molecular weight of 6000 g mol-1 was used to modify the particles because it 
provides sufficient steric hindrance to avoid agglomeration due to the magnetic nature of 
the particles. Because the human circulatory system is sensitive to objects with a size 
greater than 200 nm, the brush sized used will provide a small enough platform for 
modification with large functional moieties to stay below the size range that can be 
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filtered out. The particles dispersed in DI water was a great indicator that the particles 
were successfully modified with PEO (Figure 3.10), and TEM micrograph (Figure 3.10) 
shows a halo from the less dense polymer around the dense magnetic nanoparticles.  If 
the polymer chains were fully extended, the chain length is about 34 nm, giving a total 
polymer-particle diameter of 61 nm. When analyzing the dry diameter of 10 particles, the 
average diameter measured was 42 nm, which is within the size range expected for the 
molecular weight used to modify the 7.2 nm magnetic nanoparticles. 
 
Figure 3.10. Schematic of a magnetic nanoparticle modified with alkyne-PEO-
nitroDOPA (left) and TEM micrograph of particles after modified with alkyne-
PEO-nitroDOPA (right). 
When creating nanoparticles for biological applications, analyzing the particle-
environment interaction is important.57,131 Characterizing these particles in ionic and 
protein rich solutions is a great technique for simulating stability in biological 
environments. Using dynamic light scattering (DLS), modification of the aforementioned 
7.2 nm oleylamine coated nanoparticles with the water soluble PEO was confirmed. The 
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final hydrodynamic diameter was an average of 77 nm in water, as shown in Table 3.1. 
For drug delivery systems, this size will be able to circulate within the body without 
getting filtered out by the reticulo-endothelial system (RES).150 The particles were further 
characterized with thermogravometric analysis (TGA) (Figure 3.11) to find the surface 
loading of polymer on the surface of the particle. There was about a 95% weight loss of 
polymer, which comes out to be about 11 chains per nm2, suggesting some free polymer 
still associated with the particles after 3 days of dialysis. Initially, it was presumed that 
some oleic acid, used to suspend the particles before they were modified with polymer, 
might have been trapped on the surface during modification. TGA analysis of the 
particles before they were modified with polymer showed an 87% weight loss from 179-
233 °C due to the oleic acid. This feature is not observed in the TGA of the modified 
particles, Figure 3.11. So, the high loading of polymer on the surface could be due to 
crosslinking between the nitroDOPA endgroups that can create a large macromolecule 
that was not removed with the molecular weight cutoff used for dialysis.  
Table 3.1. DLS of magnetic nanoparticles before and after modification. 
 Z-Avg (d.nm) PDI I (%, d.nm) V (%, d.nm) N (%, d.nm) 
OA Coated 29.24 0.295 35.42±17.14 20.06±8.93 14.57±4.51 




Figure 3.11. Thermograph of particles modified with alkyne-PEO-nitroDOPA 
Although the particles are stable in water, this is irrelevant in the complex 
environment of the human body. Materials used in biological applications can be limited 
in their effectiveness due to absorption plasma proteins that can inhibit the circulation 
time in the body.151 Proteins can attach to the particles and provoke agglomeration 
rendering the particles useless. To observe how this particles system will behave in a 
simulated biological environment, phosphate buffer saline (PBS), fetal bovine serum 
(FBS), and bovine serum albumin (BSA) were added, 10% by volume (0.1 mL), to a 
dilute solution of the particles (0.9 mL, 0.1 mg of modified particles mL-1), to see how 
the hydrodynamic diameter was affected, thus indicating the colloidal stability in the 
respected media.152 As seen in Figure 3.12, there was no significant change in 




Figure 3.12. (Left) Hydrodynamic diameter by intensity of magnetic nanoparticles before 
and after modification with alkyne-PEO-nitroDOPA; size data chart available 
(Right) Hydrodynamic diameter by intensity of the particles titrated with PBS, 
FBS, and BSA. 
Now that this polymer-particle complex has been successfully synthesized and 
characterized in simulated biological environments, the functional surface can be 
modified for biomedical targeting and imaging applications. Fluorescein-azide, Figure 
3.13 (B), was then “clicked” in using a Huisgen 1,3-dipolar cycloaddition between the 
alkyne of the particle surface and the azide of the fluorescent dye molecule, using copper 
(II) sulfate and sodium ascorbate to drive the reaction.153 These particles were dialyzed 
for 3 days in the absence of light to ensure removal of excess dye, catalyst and 
byproducts. The photoluminescence spectrum (Figure 3.14) shows a maximum emission 
at 517 nm for the particles modified with fluorescein and no visible emission for the 
particles before modification.  
 75 
 
Figure 3.13. Schematic of azide modified dyes used to modify magnetic nanoparticles 
using “click chemistry.” A) carbazole modified with an azide and B) fluorescein 
modified with an azide. 
 
Figure 3.14. Image on the left shows a photoluminescence spectrum of particles before 
and after functionalization with fluorescein. Image on the right represents the 
final construction of magnetic nanoparticle with functional surface modified 
with a fluorophore. 
To demonstrate the versatility of the alkyne surface, the particles were then 
modified with equimolar amounts of carbazole and fluorescein dye, Figure 3.13 (A) and 
(B) respectively. These two dyes were chosen because their emissions are at different 











particles were modified, dialysis against water was done for 3 days to ensure excess dye 
and catalyst was sufficiently removed. Photoluminescence was then used to conform the 
modification of the particles by first exciting at 290 nm to yield a broad emission peaks at 
348 and 363 nm, Figure 3.15 (A). The same sample was then excited at 400 nm and an 
emission was observed at 417 nm, Figure 3.15 (B). 
 
Figure 3.15. Photoluminescence of mono-anchored nanoparticles after modification with 
A) carbazole dye (348 and 363 nm) and B) fluorescein dye (417 nm). 
3.5. CONCLUSIONS 
 
The design and synthesis of this specialty heterobifunctional PEO provides a great 
platform for biomedical magnetic nanoparticle research. This uncomplicated synthesis of 
such a specialized material lends itself to the production of biologically stable 
nanoparticles with an alkyne surface that provides a customizable scaffold for a variety of 
biomedical applications. 
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Synthesis of a unique heterobifunctional PEO was accomplished by ring opening 
polymerization of EO using a protected initiator and sub-sequential end group 
modifications with relative ease. This polymer is equipped with robust anchoring to 
magnetite via a catechol, biological stability via PEO, and a functional surface via an 
alkyne. Confirmed by DLS, the once water-insoluble magnetite nanoparticles, were 
stabilized in water. These functionalized particles are now capable of carrying a variety 
targeting and imaging agents, through “click chemistry,” which is represented in the 
drawing in Figure 1.4. The accessibility of the surface functionality was demonstrated by 
adding an azido-functionalized fluorescein that was detected using photoluminescence, at 
a wavelength of 517 nm. The ability to add multiple functional moieties of the surface 
was also displayed using two different dyes (carbazole and fluorescene) that emit at 
different wavelengths that could easily be characterized by photoluminescence. The 
development of this polymer-particle complex allows for a biologically stable platform to 
easily and efficiently build biomedical devices for use in any theranostic application.  
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CHAPTER 4. SYNTHESIS AND CHARACTERIZATION OF MULTI-ANCHORED 
HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE) FOR ENHANCED 




 The research and development of surface coatings for magnetic nanoparticles is 
important for improving colloid stability of these particles in biological conditions. For 
efficient delivery of the magnetic nanoparticles, they must remain stable for long enough 
in the harsh environment of the body to get sufficient concentration to the infected area. 
Improved stability can be accomplished by increasing the number of interactions between 
the surface coating and the magnetic nanoparticles to decrease the interactions of proteins 
that can interfere with colloidal stability. This chapter discusses the synthesis of a 
heterobifunctional polyethylene oxide (PEO), with an amine on one end and an alkyne on 
the other, which is chemically attached to polyacrylic acid (PAA) and subsequently 
modified with nitroDOPA to provide multiple anchoring groups per PEO chain. 
Improved stability was not only observed, by comparing it to a mono-anchored PEO in 
extreme ionic and protein rich environments, but there is an alkyne surface on the particle 
that can be modified, in water, with azide-functionalized moieties using “click chemistry.” 
4.2. INTRODUCTION 
 
Functional magnetic nanoparticles have become an important research focus for 
use in biomedical applications. These applications include magnetic hyperthermia,2,156 
magnetic resonance imaging,20,21 and cell separation.22,23 The small size and manipulation 
of magnetic properties of these materials also have potential for non-invasive diagnostics 
and treatments to improve quality of life for patients. 
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 There are a variety of ways to create functional magnetic nanoparticles, but the 
fundamental designs of these materials stay the same. Generally, in each individual 
nanoparticle, the core material is magnetic and is coated with a water-soluble material 
that is either physically or chemically adsorbed on to the surface. The core can be made 
up of an assortment of magnetic materials, including iron platinum, cobalt oxide, and iron 
oxides.139 Because these materials are synthesized using thermal decomposition methods, 
they have hydrophobic ligands that are only dispersible in organic solvents. They must be 
modified with hydrophilic materials for biomedical applications. There are a variety of 
hydrophilic surface designs that have been researched to create magnetic nanoparticles 
suspended in water, including dextran, pluoronics, and polyethylene oxide (PEO).139 
Magnetic nanoparticles for biomedical applications, like any pharmaceutical drug, 
have power in numbers. The ultimate goal is to have a high accumulation in the affected 
area without using high dosages that may affect the patient negatively. This can be 
accomplished in magnetic nanoparticle composites by designing ligands that increases 
the lifetime of the particles in the body,131 as well as taking advantage of the particles’ 
surface139 to target certain cells by exploiting over expressed receptors.  
To improve circulation of the material in the body, nanoparticles must be 
protected from nonspecific reactions from proteins in the biological environment. Using 
ligands with multiple anchoring groups has been reported for stabilizing quantum dots157 
and gold nanoparticles158 in biological conditions. Bagaria et al. found that grafting a 
sulfonated block copolymer onto the surface of 2-aminopropyl triethoxy silane (APTES) 
modified magnetic nanoparticles provided colloidal stability in brine solutions at 90 °C 
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over 30 days. They report this was due to the multiple grafting points provided by the 
number of sulfonated groups along the polymer chain to the APTES on the nanoparticle 
surface.159,160 Dr. Riffle’s research group at Virginia Tech synthesized a 
heterobifunctional PEO with a functional anchoring group comprised of three 
phosphonate zwitterions. They were able to produce extended colloidal stability in 
phosphate buffer saline (PBS) over 24 hours, which was not seen in heterobifunctional 
PEO modified with a single phosphonate zwitterions.161 Ligands with multiple robust 
anchoring groups, i.e. catechols, for iron oxide nanoparticles have also shown improved 
colloidal stability.162 In fact, Saville et al. reported that increasing the number of 
nitroDOPA groups, from one to three, per PEO chain increases the colloidal stability of 
the magnetic nanoparticles in protein rich environments significantly.131 
Designing ligands for biological targeting imaging applications can be exhaustive 
and the reactions can be inefficient. The synthesis of these ligands generally requires 
harsh solvents that must be completely removed before any biological interaction. “Click 
chemistry” was designed to bring two groups together to create a strong and stable 
linkage. Originally developed for facile protein modification, it was later used to 
efficiently modify polymers. The most common of the “click reactions” is the Huisgen 
1,3-dipolar cycloaddition between an alkyne and an azide. Na et al. have demonstrated 
this by modifying polyacrylic acid (PAA) with methyl-terminated and azide-terminated 
PEO, using multiple catechols (~6) to provide enhanced stability at different pH and salt 
concentrations. The particles also provided surface functionality through the azide that 
was reacted with alkyne-modified rhodamine B using “click chemistry.163” 
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Reported is the synthesis and characterization of a magnetic nanoparticle 
composite comprised of an iron oxide core and a functional polyethylene oxide (PEO) 
scaffold with enhanced stability in biological environments that can be tailored for a 
variety of biomedical applications using “click chemistry.” The scaffolding was created 
by first linking a specially designed heterobifunctional PEO to PAA and then modifying 
the newly formed brush with nitroDOPA for anchoring to the magnetic nanoparticle 
surface. To illustrate the enhanced stability of the aforementioned particle, it was 
submitted to a variety of simulated biological environments at body temperature and 
compared to a mono-anchored particle of similar size and composition. The multi-
anchored particles were also modified with different functional moieties to exhibit the 
flexibility and customization of the surface for a variety of theranostic applications. 
4.3. EXPERIMENTAL 
 
4.3.4. Modification of Protected amine-PEO with alkyne 
 
The procedure used is based on previous work done by Kim et al.116 Protected 
Amine-PEO-OH(2.0 g, 0.33 mmol) and sodium hydride (32 mg, 1.32 mmol) was charged 
to a 100 mL round bottom flask equipped with a stir bar. The flask was the sealed with a 
septum and purged with nitrogen for 30 seconds. THF (40 mL) was added via syringe 
and the reaction was brought to 0 °C using an ice bath. Propargyl bromide (0.15 g, 1.32 
mmol) was slowly added via syringe over 30 minutes. All the reactants were left to stir 
for another 30 minutes at 0 °C. The flask was then removed from the ice bath and 
brought to room temperature to react for 24 hours. The final solution was filtered to 
remove excess sodium hydride and precipitated with DEE twice to collect polymer.  
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1HNMR (300 MHz, CDCl3), δ (ppm): 3.56 (m, CH2-CH2-O), 2.43 (s, -O-CH2-
C≣CH), 4.19 (s, -O-CH2-C≣CH), 2.75 (m, (TMS)2-N-CH2-) 1.19 (m, TMS). 
4.3.5. Deprotection of amine-PEO-alkyne 
 
The deprotection of the amine was accomplished by dissolving the polymer (1.8 g, 
0.30 mmol) into methanol and then slowly adding 20 drops of a 1 M HCl solution and 
stirring over night under a nitrogen head. The product was precipitated with DEE (2x) 
and the solid was collected. The cleavage of the bis(trimethylsilyl) (BTMS) group was 
confirmed by HNMR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.65 (m, CH2-CH2-O), 2.44 (s, -O-CH2-
C≣CH), 4.19 (s, -O-CH2-C≣CH) 
4.3.6. Modification of poly(acrylic acid) with amine-PEO-alkyne 
 
In a 100 mL round bottom flask equipped with a stir bar and condenser, amine-
PEO-alkyne (0.8 g, 0.14 mmol) was dissolved in 40 mL of THF and brought to 0 °C. 
DCC (0.03 g, 0.14 mmol) was then added and stirred for 30 minutes under constant 
nitrogen purge. Finally PAA (0.05 g, 0.03 mmol) and DMAP (0.003 g, 0.03 mmol) was 
added and brought to reflux at 70 °C for 2 days. After two days, the solution was filtered 
to remove any undissolved reactants and precipitated with DEE. The polymer was then 
dissolved in DCM and precipitated with DEE (2X) and the final solid was characterized 
by 1HNMR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.56 (m, CH2-CH2-O), 2.43 (s, -O-CH2-
C≣CH), 4.20 (s, -O-CH2-C≣CH), (b, 1.20-2.25, PAA) 
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4.3.7. Modification of PAA-PEO-alkyne with NitroDOPA 
 
To a 100 mL flame dried, round bottom flask equipped with a stir bar, PAA-PEO-
alkyne (0.4 g, 0.0015 mmol) was dissolved in DMF and brought to 0 °C using an ice bath. 
EDC (0.002 g, 0.013 mmol) and TEA (2.0 µL, 0.015 mmol) were both added while 
purging with nitrogen and stirred at 0 °C for 30 minutes. The final reactants, nitroDOPA 
(3.0 mg, 0.012 mmol) and DMAP (0.3 mg, 0.003 mmol), were added under a constant 
nitrogen purge and stirred for another 30 minutes. Finally, the reaction was removed from 
the ice bath and brought to 80 °C for 5 days. The purification was accomplished by 
bringing the reaction to room temperature and filtering out any solids. The polymer was 
then precipitated with DEE and the solid was dissolved in chloroform. Vacuum filtration 
was then used to remove any excess nitroDOPA. The filtrate was collected and polymer 
was collected by precipitation in DEE (2x). The polymer was then dissolved in DI water 
and dialyzed using 1000 g mol-1 MWCO dialysis membrane. Product was confirmed by 
1HNMR and FTIR. 
1HNMR (300 MHz, CDCl3), δ (ppm): 3.62 (m, CH2-CH2-O), 2.43 (s, -O-CH2-
C≣CH), 4.19 (s, -O-CH2-C≣CH), (b, 1.20-2.25, PAA). nitroDOPA: 6.12 and 6.70 (s, CH 
in ring). 
4.3.8. Modification of Magnetic Nanoparticles with Polymer 
 
NitroDOPA-PAA-PEO-alkyne (0.2 g, 0.0007 mmol) was dissolved in 10 mL of 
chloroform. 7.2 nm particles in hexane (1 mL, 2 mg of Fe3O4 mL-1) were slowly added 
over 30 minutes while using sonication. Once all the particles were added, the solution 
was stirred overnight. The particles were then precipitated with hexane and dispersed in 5 
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mL of ethanol to dissolve any of the displaced oleylamine and precipitated with hexane to 
collect the polymer-modified particles. The particles were then dispersed in DI water and 
dialyzed for 2 days. 
4.3.9. Cell Viability Studies 
 
Materials used for cell viability were as follows: 96 well plate was purchased 
from BD biosciences, CCD18-Co cells, L929 cells (ATCC® CCL-1TM) and EMEM (30-
2003TM) where purchased from ATCC and used as received, phosphate buffer solution 
from Sigma Aldrich was autoclaved prior to usage, trypsin-EDTA (25-053-Cl) and 
trypsin Blue (25900-Cl) were purchased from Cellgro and used as received. 
The cytotoxicity of the modified magnetic nanoparticles particles was done by 
adding 200 µl of L929 cells (4.5 x 105 cells per well)/ CCD18-Co (2 x 104 cells per well) 
into a two 96 well plate and incubated for 24 hours at 37 °C, 5% CO2 atmosphere. The 
particles were then plated, in quadruplicate by adding 1, 2, 3, 4, 5, 6, 8 µl and a control 
with no particles. One plate was incubated with particles for 24 hours and the other was 
incubated for 48 hours before analyzing. MTS assays were preformed using a modified 
protocol suggested by Promega. The plates were washed with PBS twice followed by the 
addition 100 µl of media before 20 µl of CellTiter 96® AQueous One Solution Reagent 
was added to each well. The plates were then incubated at 37 °C at 5% CO2 atmosphere 
for 4 hours before absorbance at 490 nm was read using 96-well plate reader. 
4.3.10. Modification of particles with Azido-Cy5.5 Dye 
 
To 10ml of DI water, 0.5 mL of modified particles (0.7 mg of modified particles 
mL-1) was added. The azido-Cy5.5 (0.003 mmol) was added to solution followed by 
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CuSO4 (0.013 mmol) and sodium ascorbate (0.003 mmol). The reaction was then covered 
with foil and stirred at 28 °C for 12 hours. The particles were then removed from heat 
and dialyzed for 3 days against DI water. 
 
4.4. RESULTS AND DISCUSSION 
 
A heterobifunctional PEO was synthesized using a combination of ring opening 
polymerization and end group modification, as portrayed in Figure 4.1. Using potassium 
bis(trimethylsilyl)amide solution has been used as an anionic initiator, to ring open 
elthylene oxide  to produce PEO with a protected amine at one end and a free alcohol at 
the other.164 NMR displayed methylene shifts of PEO at 3.56 ppm and the adjacent 
hydrogen to the protected amide group at 2.75 ppm. Using propargyl bromide in the 
presence of NaH, the free alcohol on the PEO was substituted with propargyl end group, 
indicated by peaks 2.43 and 4.19 ppm in the 1HNMR. Then using a 1M HCl solution, the 
TMS that was protecting the amine was removed, which was seen from the absence of 
the shift at 1.19 ppm. 
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Figure 4.1. Schematic of synthesis and end group modification to yield 
heterobifunctional PEO (amine-PEO-alkyne) 
The heterobifunctional PEO prepared was now primed to react with the 
carboxylic acids of PAA, as presented in Figure 4.2. Using DCC coupling, the amine-
PEO-alkyne was reacted with the carboxylic acids of PAA, targeting a 5:1 ratio of PEO 
to PAA chain.163 A broad peak at 1.20-2.25 ppm confirmed the presence of PAA after the 
reaction. The peaks of the propargyl end group were still present at 2.43 and 4.20 ppm. 
Using the ratio of integrals between the α hydrogen of the PAA (25H) and the single 
proton on the alkyne terminus of the PEO (1H) the grafting density on the PAA was 
found to be approximately 6 chains of PEO per PAA. The FTIR spectrum in Figure 4.3 
also confirms the presence of the alkyne at 3237 cm-1, the carboxyl stretch at 1648 cm-1 





































Figure 4.2. Schematic of step taken to synthesize multi-anchored particles. 1) 
Modification of PAA with amine-PEO-alkyne. 2) Modification of PAA-PEO-




Figure 4.3. FTIR spectra of PAA (red) and PAA-PEO-alkyne (blue). Peak at 1728 cm-1 
is attributed to carboxyl from PAA, and the peaks at 1648 and 1531 cm-1 are 
attributed to the carboxyl amide bond between amine-PEO-alkyne. 
Using EDC coupling, PAA-PEO-alkyne was modified with nitroDOPA, in a 10:1 
ratio.  An excess of nitroDOPA was used to ensure there is increased anchoring when 
modifying the iron oxide nanoparticles. NitroDOPA-PAA-PEO-alkyne, after purification, 
was immediately dissolved in chloroform and used in the modification of nanoparticles. 
Using sonication while slowly adding particles to the polymer solution helps facilitate the 
ligand exchange and ensure maximum surface coverage. The transfer of particles to water 
was a good indication of a successful modification. Using DLS and TEM, surface 
modification was confirmed by an increase in hydrodynamic radius and polymer halo 
around the dense magnetic nanoparticle, Figure 4.4. The surface coverage of polymer on 
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the particle was determined by TGA, Figure 4.5. There was an 81.3% weight loss, from 
372 °C to 415 °C, from the nitroDOPA-PAA-PEO-Alkyne (9.49 mg). 
 
Figure 4.4. TEM micrograph (left) of multi-anchored particles and DLS (right) of the 
modified particles in DI water. 
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Figure 4.5. TGA thermogram of multi-anchored magnetic nanoparticles, 81.3% weight 
loss. 
The particles were analyzed with FTIR to corroborate the DLS and make sure it 
had the desired surface functionality. As seen in Figure 4.6, the peak at 3237 cm-1 
confirms the presence of the alkyne165 as well as the presence of carboxylic acids from 
PAA (1711 cm-1) and amide linkages (1643 and 1561 cm-1) from the nitroDOPA and/or 
PEO to the PAA.  
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Figure 4.6. FTIR spectrum of multi-anchored particles. A) Alkyne group on the surface 
of the particle. B) Carbonyl stretching of PAA (1711 cm-1). C and D) Amide-
carbonyl stretch (1643 and 1561 cm-1) indicating modification of PAA. 
The particles were then subjected to a series of biological simulations to establish 
if the multi-anchoring enhances the stability compared to mono-anchored modified 
particles, which are previously reported. PBS is a buffer solution that matches the ionic 
strength of the human body and is commonly used in biological research. Each particles 
solution (0.1 mg/mL) was titrated with 10, 30, 50 and 100% by volume of 1 N PBS 
solution and the hydrodynamic diameter was observed using DLS. The results shown in 
Figure 4.7 show the enhanced stability of the multi-anchored particles compared to the 
 92 
mono-anchored. At 100% by volume of PBS with the mono-anchored particles there is an 
obvious decrease in original particles size and the formation of large clusters greater than 
1000 nm. No visible effect on size was observed for the multi-anchored particles.  
 
Figure 4.7. Stability studies comparing mono and multi-anchored particles. A) DLS of 
mono-functional particles in 50% by volume PBS at 37 °C; B) DLS of multi-
functional particles in 50% by volume PBS at 37 °C; C) DLS of mono-anchored 
particles titrated with PBS from 0-100% by volume; D) DLS of multi-anchored 
particles titrated with PBS from 0-100% by volume; 
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The human body operates at temperatures greater than room temperature, so using 
DLS, the hydrodynamic diameter of the particles was measured in a 50% by volume of 
PBS (1N) at the average human body temperature, 37 °C, for 5 minutes. In Figure 4.7, 
the multi-anchored particles show no change in hydrodynamic diameter in this simulated 
environment. The mono-anchored size distribution, although stable in the same ionic 
environment, broadens with an increase in temperature. The multiple nitroDOPA groups 
increase the amount of interactions with the surface of the iron oxide nanoparticles 
keeping the steric interactions intact that are involved in keeping the particles discrete 
and stable.131 
Table 4.1 Presents the results of the time dependence studies done in a 50% FBS in 





DI Water 118.90 105.71 
50% FBS 121.00 100.79 
50% FBS at 70 °C 122.40 107.80 
50% FBS over 24hrs*  203.65±30.14 95.73±21.85  
*average hydrodynamic diameter over 24 hours; measurements taken every 12 minutes 
Time dependence studies, Table 4.1 were done in FBS, fetal bovine serum, on 
both the mono and multi-anchored particles to see how their stability compares to each 
other in a high temperature, protein rich environment. One milliliter of each particle 
system, each with a concentration of about 1 mg of multi-anchored particles mL-1 in DI 
water, was added to a cuvette and 500 µL of FBS (0.125m mg of hemoglobin) was 
titrated into the cuvette and vortexed for 20 seconds. The particles were first measured at 
room temperature and the mono-anchored particles had approximately a 3nm increase in 
diameter. The multi-anchored particles had a slight decrease in hydrodynamic diameter of 
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about 5 nm. The hydrodynamic diameter of the particles was measured at 70 °C and only 
a slight increase in particles size was observed; 1.4 nm for the mono-anchored and 7.1 
nm for the multi-anchored. The samples were then measured again at 70 °C every 12 
minutes for 24 hours. The mono-anchored particles’ average hydrodynamic diameter 
over the 24 hours almost doubled in size from 122.4 nm to 203.56 nm. The size increase 
is indicative of clustering that can occur when ligands are displaced by proteins in the 
environment, decreasing the steric hindrance. This phenomenon was not observed for the 
multi-anchored particles, the average size over 24 hours was measured to be 95.73 nm. 
Statistical analysis, using one way ANOVA, showed there was a statistically significant 
difference between the average sizes measured for the mono and multi-anchored particles 
(p<0.0001, n=108). This data shows how crucial multiple anchoring groups are for 
stability in harsh biological environments. 
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Figure 4.8. Cell viability of L929 cells after exposure with multi-anchored particles for 
24 and 48 hours at different concentration of iron. (mean± standard dev.; n=3) 
When synthesizing materials for biomedical applications, evaluating of its toxicity 
is very important.166,167 An MTS assay was done on the muti-anchored particles to 
determine if there is a negative cytotoxic effect. MTS assay utilizes (3-[4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) dye that is processed into 
formazan by living cells that has an absorbance at 490nm that can be quantified.168 The 
viability is determined by counting the live cells incubated with the particles and 
comparing them to the number of proliferated cells in the control, cells that have not been 
exposed to the multi-anchored magnetic nanoparticles. L929 mouse fiberblast cells are 
used in many publications to test the cytotoxicity of magnetic nanomaterials.169-173  
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Figure 4.8 shows the cell viability results of incubated multi-anchored particles 
over 24 and 48 hours at different concentrations of iron in media with L929 cells, ranging 
from 8 to 63 mg mL-1 and MTS assay was done to quantify the live cells. The particles 
that were incubated for 24 hours showed a decrease in viability compared to the control, 
of approximately 25% on average, for all concentrations. Statistical analysis using a one-
way ANOVA showed that there was no statistically significance difference between the 
mean of the control and all the concentrations tested (p=0.18). This indicates that there is 
no significant effect of concentration on the cytotoxicity of the multi-anchored magnetic 
nanoparticles. The L929 cells were also exposed to the multi-anchored nanoparticles for 
48 hours to see if there may be a time dependence toxicity that could not be seen in the 
24 hours study. Statistically, ANOVA analysis showed that there was no statistically 
significant difference between the means of the control and the different concentrations 
over 48 hours (p=0.42). In fact, cell growth was observed after 48 hours of incubation.  
Below, in Figure 4.9, micrographs of the L929 cells with different concentrations of 
multi-anchored nanoparticles were taken after 24 hours of treatment. In Figure 4.9, 
optical micrographs of the cells showing the control and the cells incubated with 63 mg 
ml-1 of Fe3O4 nanoparticles particles after 24 hours. Healthy cells, circled in green in 
Figure 4.9 (A), are extended and attached to the bottom of the cell well plate. Dead cells 
are detached from the cell well plate and ball up; an example of a dead cell is circled with 
a red circle in Figure 4.9 (B). Optical micrographs of the cells after incubated for 48 
hours are displayed in Figure 4.10 to show there was no visible difference between the 
control and cells exposed to 63 mg ml-1 Fe3O4 nanoparticles. 
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Figure 4.9. Micrographs of cells incubated with multi-anchored magnetic nanoparticles 
after 24 hours. A) Control, B) 63 mg of Fe3O4 mL-1, respectively. All scale bars 
are 100 micrometers. Green circle shows an example of a living cell and red 
circle shows a dead cell. 
 
Figure 4.10. Micrographs of cells incubated with multi-anchored magnetic nanoparticles 
after 48 hours. A) Control, B) 63 mg of Fe3O4 mL-1, respectively. All scale bars 
are 100 micrometers. All scale bars are 100 micrometers. Green circle shows an 
example of a living cell and red circle shows a dead cell. 
To demonstrate the availability of the surface to be functionalized with an azido-
conjugated molecule, an azido-Cy5.5 was “clicked” on to the surface of the polymer-
magnetic nanoparticle complex in water at 28 °C for 12 hours in the absence of light. 
Sodium ascorbate was used to reduce copper (II) sulfate in solution to catalyze the 
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reaction and yield the 1,4 conformation of the 1,2,3, triazole.109 Cy5.5 is an example of a 
near infrared (NIR) dye that has an emission range of (700-1000 nm).174 After dialysis for 
3 days, the modified particles were analyzed using photoluminescence by exciting at 650 
nm and observing an emission peak at 705 nm, Figure 4.11. The multi-anchored particles, 
not modified with Cy5.5, were also excited at the same wavelength, but no emission was 
observed. A NIR dye was chosen to modify the particles because it can easily be detected 
with photoluminescence and it shows that these particles can be modified with a 
molecule that is used. 
 
Figure 4.11. Photoluminescence of multi-anchored particles before and after being 




The goal of this work was to produce a PEO ligand to improve the stability of 
magnetic nanoparticles for biomedical applications. This was accomplished by using 
poly(acrylic acid) as the spine to hold multiple anchoring groups per PEO chain. Using 
anionic polymerization of ethylene oxide, initiated by potassium bis(trimethylsilyl)amide 
solution, and end group modification a heterobifunctional PEO was synthesized with an 
alkyne on one end that can easily functionalized using “click chemistry” and an amine 
that could be reacted with the carboxylic pendants of poly(acrylic acid). The use of 
nitroDOPA gave a stable anchor to the iron oxide surface. Increased stability in extreme 
biological environments was demonstrated by comparing it to mono-anchored particles of 
a similar nature in ionic and protein rich solutions. Not only is this polymer-magnetic 
nanoparticle complex stable in harsh biological environments, but toxicity studies on 
these particles show statistically insignificant decrease in viability as a function of 
concentration and incubation time, up to 48 hours. The functionality of the surface 
incorporated in the design of this stabilizing ligand was displayed by successfully 




CHAPTER 5. VERSATILITY OF A MULTI-ANCHORED HETEROBIFUNCTIONAL 




When designing the polymer-magnetic nanoparticle complex described in 
Chapters 3 and 4, the initial application in mind was targeted magnetic hyperthermia for 
the treatment of cancer. When discussions arose with different research groups in fields 
of biology and bioengineering, the desire for magnetic nanoparticles suspended in 
aqueous media that can be tailored to their specific applications was a problem they were 
not equipped to solve. The particles synthesized in the aforementioned in Chapters 3 and 
4, originally designed for targeted magnetic hyperthermia of cancer, were now needed for 
other studies, Figure 5.1, involving alternative antibiotics,175 effects of nanoparticles on 
biofilms,176 and a new approach of thernostics for cancer early detection and treatment.177 
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Figure 5.1. Schematic summarizing the flexibility of the heterobifunctional PEO 
scaffolding used to modify magnetic nanoparticles. A) magnetic nanoparticle 
modified with alkyne-PEO-nitroDOPA, B) micrograph of clustered E. coli using 
magnetic nanoparticles functionalized with Tr-32, C) 3D fluorescent imaging of 
biofilms treated with magnetic nanoparticles with Cy5.5 dye, and D) Chelated 
64Ga ligand used to modify magnetic nanoparticles for SPECT/MR imaging. 
BACTERIAL AGGREGATION AND TREATMENT USING MAGNETIC 
HYPERTHERMIA 
 
Dr. Tzeng’s group in the biology department at Clemson University were working 
on clustering different types of dangerous bacteria that is commonly found in an infected 
colon and applying an alternating magnetic field to disrupt their growth. They needed 
magnetic nanoparticles coated with a tri-carbohydrate that will actively target the 
bacteria’s surface. Carbohydrates, linked to nanoparticles, have been found to bind to 
bacterial surface receptors, called adhesins, for use in detection and treatment of bacterial 
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infections.121 The mono-anchored magnetic nanoparticles with an alkyne surface, 
described in Chapter 3, was modified with an azido tri-saccharide using “click chemistry.” 
The solution was then dialyzed for 3 days before given to Dr. Tzeng’s research group 
where they then used them to cluster E. coli K99 bacterial cells. 
 
Figure 5.2. Structure of Tr32 tri-saccharides that was used to target E. coli K99 bacteria. 
Aggregation studies were done on both the mono-anchored nanoparticles and the 
particles modified with Tr-32, Figure 5.2. Both of the particles complexes were added to 
E. coli K99 bacterial cells and mixed for 30 minutes at room temperature. The Tr-32 
nanoparticles were also added to E. coli O157:H7, as a negative control. An aliquot was 
then taken and observed under an optical microscope, fluorescent and phase contrast 
micrographs are displayed in Figure 5.3. As expected visible aggregation did not occur, 
Figure 5.3 (A) and (B), with the mono-anchored particles with the E. coli K99 because of 
the lack of Tr-32 on the surface of the particles. To study the specificity of the binding of 
Tr-32 to E. coli K99, the modified particles were added to a different bacterial cell, E. 
coli O157:H7. As seen in Figure 5.3 (C), there was no aggregation observed. When the 
Tr-32 modified particles were added to E. coli K99 the bacterial cells were aggregated to 
structures over 100 µm larger, Figure 5.3 (D). A colony forming unit (CFU) assay was 











Tr 32:  Neu5Ac(a2-3)Gal(b1-4)Glcb-Sp




























































data was conclusive, Figure 5.3, showing no significant reduction of CFU for the mono-
anchored particles and a one-log reduction of CFU when the E. coli K99 cells were 
targeted and agglomerated.  
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Figure 5.3. Fluorescence (left column) and phase-contrast (right column) microscopy of 
A) E. coli K99 in PBS, B) E. coli K99 with mono-anchored particles 
(unmodified), C) E. coli O157:H7 with Tr-32 modified particles, D) E. coli K99 




Figure 5.4. E. coli treatment with mono-anchored particles (unmodified) and Tr-32 
modified particles. Data represented as Mean ± SD (n=3) 
The E. coli K99 bacteria treated with the Tr-32 modified magnetic nanoparticles 
were characterized in an alternating current (AC) calorimeter to use magnetic 
hyperthermia to destroy the bacterial cells. Each sample was placed inside a temperature 
controlled water bath (45 °C) inside of a 5-turn, 2” in diameter copper coil. At 207 KHz 
and 480 A, we were able to produce an alternating magnetic field of 32.4 to 38.8 KAm-1. 
Initial experiments were done at 37 °C to emulate body temperature but because the 
concentration of magnetic nanoparticles was low, for the max field and frequency, the 
water dissipated the energy and temperature at which the bacteria will die could not be 
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reached. The temperature was then increased to 45 °C for all measurements so the 
amount of energy needed to increase the temperature for the hyperthermia treatment of 
the bacterial cells, at 47°C, could be accomplished. The samples were put in the 
alternating magnetic field for 5, 10, 15, 30 and 60 minutes. CFU assay was then used to 
quantify and compare the treatments of different lengths. In Figure 5.4, the histogram 
shows that there was no significant change was observed in the control in all experiments. 
The mono-anchored particles exposed to a field for up to 15 minutes showed no 
significant loss of colony forming units. Thirty and sixty minute treatments yielded a one-
log reduction in CFUs. All the samples were equilibrated to 45 °C before the magnetic 
field was applied, so the magnetic nanoparticles had to increase the temperature of the 
environment above temperature set by the water bath to have significant cell death. The 
particles modified with Tr-32 after 5 and 10 minutes in the magnetic field doubled the 
CFUs, which is hypothesized to the particles breaking up the aggregates from the motion 
of the particles in the field. After 15 minutes of treatment, there was a one log reduction 
and a two log reduction after 30 and 60 minutes which is a statistically significant 
decrease in CFUs,(p<0.0001). The two log reduction of CFUs for E coli K99 are on the 
same order of a many disinfectants that claim to kill 99.999% of bacteria. The efficiency 
of targeting and killing bacteria, shown with these initial hyperthermia results, is proof 
that these polymer-magnetic nanoparticle complexes are a viable alternative to antibiotics. 
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Figure 5.5. Hyperthermia treatment of E. coli with mono-anchored particles 




Figure 5.6. A) MTS assay of mono-anchored nanoparticles in human colon cells 
(CCD18-Co). B) MTS assay of Tr-32 modified nanoparticles in human colon 
cells (CCD18-Co). 
MTS assays were performed on the mono-anchored magnetic nanoparticles and 
Tr-32 modified nanoparticles in human colon cells (CCD18-Co). This specific cell line 
was chosen because of where the targeted bacteria are located. In Figure 5.6 (A), there 
were no significant cytotoxic effects of the unmodified particles to the colon cells. After 
the particles were modified with Tr-32, there were still no significant cytotoxic effects 
observed of the nanoparticles, Figure 5.6 (B).  
The initial work reported in this section shows that targeting, clustering, and 
hyperthermia of a specific type of E. coli is possible if time in the magnetic field is long 
enough. This can be improved by increasing the concentration and/or the size of the 
magnetic particles to increase the size of the clustering of the bacterial cells and the 
amount of heat generated to induce cell death. In the future work it will also be important 
to determine the ideal number of tri-saccharides per particle, not only for Tr-32 but other 
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tri-saccharides used for targeting specific bacteria, that is needed for clustering for more 
efficient particle design. 
 
INTERACTIONS OF MAGNETIC NANOPARTICLES IN BACTERIAL BIOFILM 
 
Nanoparticle research is important for the advancement in biomedical 
applications but there is also a concern on the impact of these materials on the 
environment. Biofilms are an important source of nutrients for ecosystems and is the base 
food supply for a lot of organisms.178 Biofilms can contain Legionella bacteria found in 
industrial settings that is very harmful to humans because of potential outbreak of 
Legionnaires’ disease, so prevention and treatment of biofilms is very important.179 
Legionnaires’ disease is a combination of diseases involving pneumonia and flu-like 
illness that makes it difficult to diagnose without microbiological testing.180 In fact, it is 
such a problem in some areas of the world that statistical and impact research is being 
published this year for incidences that occurred in Glasgow, UK and Christchurch, New 
Zealand.181 
Dr. Tamara McNealy’s research group at Clemson University is currently 
studying the effects of different types of metal nanoparticles on Legionella pneumophila 
biofilms that are found in natural and man-made environments.182 Raftery et al. 
characterized Legionelle pneumophila biofilms after they have been subjected to gold, 
platinum, silver and iron oxide nanoparticles. They discovered that the platinum and iron 
oxide nanoparticles had the largest reduction in the biofilm after 48 hours of exposure by 
analyzing and comparing the surface roughness of the metal nanoparticle treated and a 
control.176 
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They were able to conclude that there was an adverse effect, but they were not 
able to visualize where and how the particles interact with the biofilms. Their group 
approached needed a water-soluble magnetic nanoparticles with a fluorescent dye so a 
Leica GSD microscope could be used to observe where polymer-magnetic nanoparticles 
settle in a biofilm. Polymer-magnetic nanoparticle complexes synthesized in Chapter 4 
was modified with and azido Cy5.5, as described in section 4.3.10. Cy5.5 is a near IR dye 
that emits at 707 nm, which was far enough down the visible light spectrum from the 




Figure 5.7. 3D Micrographs of L. pneumophila before and after treated with 
nanoparticles. A) Confocal micrograph of biofilm control. B) Confocal 
micrograph of biofilm treated with 1 µg of Fe/L of Cy5.5 modified magnetic 
nanoparticles. C) GSD micrograph of control. D) GSD micrograph of biofilm 
treated with 1 µg of Fe/L of Cy5.5 modified magnetic nanoparticles. 
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Figure 5.8. A) Biomass, B) Thickness, and C) Roughness analysis of biofilms before and 
after Cy5.5 particles were added. Data represented as Mean ± SD (n=3) 
There is definite disruption in the biofilm, as seen in Figure 5.7 (B), as compared 
to the control, Figure 5.7 (A). There is a visible decrease in the bio-volume after 
treatment with the Cy5.5 modified magnetic nanoparticles. Characterization of the 
control biofilm and the biofilm treated with particles was analyzed for change in biomass, 
thickness, and roughness. There was a statistically significant decrease in biomass after 
the addition of nanoparticles, (Figure. 5.8 (A), p=0.008, t-test). There was also a 
significant decrease in the thickness of the film, Figure 5.8 (B), confirming the loss of 
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height of biofilm due to the magnetic nanoparticles (p=0.021, t-test). Finally roughness 
was quantified, Figure 5.8 (C), and the results show an almost 40% increase compared to 
the control.  Figure 5.8 (C) and (D) are before and after particle addition, respectively. 
The image for the control was taken after being exposed to specific wavelength and then 
scanned to read the excitation. Figure 5.9 is an overlayed 3D image that was excited at 
about 508 nm to image the biofilm (green) and then was excited at about 673 nm to 
image the Cy5.5 modified magnetic nanoparticles (red). The magnetic nanoparticles are 
being internalized and dispersed into the biofilm; because they are discrete magnetic 
nanoparticles modified a water-soluble ligand. The structure allowed the nanoparticles to 
enter gaps in the biofilms and destabilize the structure of the matrix. This phenomenon is 
difficult to observe with fluorescent confocal microscopy. This initial work will be able 
to give more information about how these nanoparticles are interacting once inside of the 
matrix that will help understand the mechanism used for biofilm reduction and can help 




Figure 5.9. Side profile of GSD image of biofilm (green) modified with Cy5.5 magnetic 
nanoparticles (red) 
MULTIFUNCTIONAL DIAGNOSTIC PROBE FOR SPECT/MR IMAGING 
 
Improving the efficiency of materials used for theranostics is very important for 
early detection and treatment, especially for many types of cancers that can metastasize 
rapidly. Dr. Urs Häfeli from the University of British Columbia proposed that combining 
multiple imaging techniques, magnetic resonance imaging (MRI) and single-photon 
emission computed tomography (SPECT), can give provide more information to medical 
practitioners to better diagnose their patients.177 SPECT requires radiotracers (radioactive 
iodine, indium and technetium) in very low concentrations for a measureable signal, but 
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cannot provide anatomic information because of its poor special resolution. To detect the 
locations of abnormalities, MRI is a much better tool for examining tissue because it uses 
contrast agents, such as magnetic nanoparticles, that magnetically relax as a function of 
its molecular environment.183 So combining these two great techniques will require a 
material that can facilitate radiotracers for high sensitivity and superparamagnetic 
nanoparticles for high spatial resolution.  
The polymer-magnetic nanoparticles that have been described in Chapter 4 were 
the perfect solution for creating a multifunctional diagnostic probe. Some of the multi-
anchored magnetic nanoparticles, Chapter 4, was shipped to their laboratories in 
Vancouver and they were able to successfully modify the particles with 67Ga.  
 
Figure 5.10. Schematic 1,4,7-triazacyclononane-1,4,7-triacetate (NOTA) ligand that is 
commonly used to chelate 67Ga radiotracer. 
The functionalization of the multi-anchored magnetic nanoparticles with a radio 
tracer was accomplished by first modifying the particles with an azide ligand,184,185 
Figure 5.8, using copper(II) sulfate and sodium ascorbate to create copper(I) catalyst in 
situ, that has the ability to chelate rare earth metals. After the particles were modified, 
they were dialyzed against water for 2 days and then lyophilized. The particles were then 
dispersed in water and mixed with 67GaCl3, shaken for twenty minutes, centrifuged with a 














present, there was an average of 68% labeling efficiency. This is very new data and 
repetition of modification should be done to ensure labeling of 67Ga. Once these materials 
have been thoroughly characterized, their biodistriubtion and ability to monitor 
biomolecular processes should be studied to see how well these particles survive in situ 
using mice models. 
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CHAPTER 6. FUTURE WORK 
 
Magnetic nanoparticles are one of the most fascinating materials to study because 
their applications are limitless. Designing different polymer surfaces for magnetic 
nanoparticles can provide a very useful tool for therapeutics and diagnostics that can be 
tailored to individual patient’s need. The original frustration of creating made to order 
heterobifunctional PEO for magnetic nanoparticles, with different surface chemistries to 
further research in different research groups brought about the need for creating a 
functional scaffolding that could create a batch of universal biologically stable magnetic 
nanoparticles. This universal particles design using PEO has great potential for 
fundamental research in magnetic nanoparticles in biomedical applications. The control 
of molecular weight and end group functionality inherent in anionic ring opening 
polymerization of ethylene oxide will allow researchers to study the effect of molecular 
weight and surface chemistry on biological phenomena, i.e. targeting, heating efficiency, 
and biodistribution. 
It has been shown that the design and synthesis of a universal ligand is possible 
on small scales because of limitations of reaction times and cost of materials. For these 
universal magnetic nanoparticle complexes to become a viable alternative to synthetic 
drugs already on the market, scaling up is necessary. So, designing new initiators that can 
efficiently polymerize ethylene oxide to provide the desired functionality and molecular 
weight will improve yields because there will be a decrease the number of end group 
modifications. One possible idea is to synthesize an initiator from propargyl alcohol, or 
amine, where the terminal carbon-hydrogen bond (C-H) of the alkyne is protected. This 
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can be done using a trimethylsilyl group, to protect the acidic proton of the alkyne from 
the caustic environment generally needed to create the anion that initiates the ring 
opening of ethylene oxide, Figure 6.1. Anionic ring opening polymerization of ethylene 
oxide using this method will allow for the production of various molecular weights with 
narrow distributions. 
 
Figure 6.1. Proposed anionic ring opening polymerization of ethylene oxide using a 
protected propargyl alcohol as an initiator. 
Once the process of synthesizing specialized heterobifunctional PEO with an 
alkyne on one end for easy functionalization and a catechol on the other end for strong 
binding to metal nanoparticles is streamlined, a large library of polymer-magnetic 
nanoparticle complexes of various molecular weights and metal core diameters is 
possible in the foreseeable future. Aliquots from this library could then be easily 
modified due to the alkyne surface, using “click chemistry,” with a variety of functional 
moieties specific to the desired application. Some examples of functional moieties that 
can be used are fluorescent dyes for imaging,155 rare earth metals for temperature 
sensing,186 active targeting drug delivery,187 radiotracers to improve diagnostic 
techniques,148 and/or a combination of them to create a multifunctional device, a 















Figure 6.2. Magnetic nanoparticle functionalized with a variety of functionalities on the 
same nanoparticle. From top to bottom: moiety that can chelate different metals, 
folic acid to target overexpressed folate receptors, and Cy5 NIR dye that can be 
used for imaging through human tissue. 
 
Magnetic nanoparticles that are modified with multiple binding groups per 
polymer chain have been shown to increase the steric stability in biological environments. 
They have been synthesized in a variety of ways using multi-functional initiators or 
modification of PAA to make brushes.131,163 Atom transfer radical polymerization 
(ATRP) could be used to copolymerize a heterobifunctional PEO analogue with an 
alkyne on one end and a methacrylate on the other with a catechol methacrylate. This 
approach can synthesize a block copolymer that is water-soluble, has a surface that can 







































































metal oxide surfaces, schematic in Figure 6.3. The heterobifunctional analogue would be 
synthesized by anionic ring opening polymerization of ethylene oxide using a protected 
propargyl alcohol. Then though end group modification, it will be modified with a 
methacrylate using methods discussed in section 2.10.4. The dopamine analog would first 
be protected as an acetonide188 and then reacted with methacroyl chloride via a 
substitution reaction. Once the analogs are synthesized, using copper(I) chloride and 2,2’ 
bipyridyl (Bipy) to radically polymerize them together and then the catechol could be 
deprotected with acid and then magnetic nanoparticles could be modified. This is another 
example of a type living polymerization that can yield narrow molecular weight polymers 
with control of each block length189 that can be used to study the optimal ratio of PEO to 
catechol needed for creating biologically stable magnetic nanoparticles. 
 
Figure 6.3. Schematic of ATRP polymerization of PEO-alkyne and catechol-
methacrylate block copolymer. 
  
Well characterized materials for biomedical applications is important for creating 


























patients. This same library can be used for fundamental research in understanding how 
particles interactions (determined by molecular weight, magnetic core size, concentration 
and surface chemistry) affect the SAR in an alternating magnetic field.190  
The surface functionality of an alkyne on the magnetic nanoparticles also 
facilitates crosslinking the particles using “click chemistry” to form clusters of magnetic 
nanoparticles, Figure 6.4, which can offer improved magnetic properties. Using a short 
chain molecule with an azide on both sides can be used to link the alkyne surface of the 
magnetic nanoparticles together. The controlled clustering of the particles will create a 
different anisotropy and interaction that will increase the saturation magnetization of the 
particles.191 This approach to clustering magnetic nanoparticles will still have an alkyne 
functional surface that can be modified further with targeting and imaging moieties using 
“click chemistry.”  
 
Figure 6.4. Schematic of clustered nanoparticles via “click chemistry” using a bis-azide 
to link the alkyne surface of the magnetic nanoparticles. 
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Using targeting agents for delivering the magnetic nanoparticles to infected areas 
is very useful for increasing the efficiency of the treatment because of the increase 
concentration at the site to initiate endocytosis.192 Unfortunately, this usually only 
happens at the surface where the receptors are over-expressed and are not internalized, 
and will require multiple treatments to completely remove tumor. One way to facilitate 
the internalization of nanoparticles into infected cells is by combining different charges 
and targeting moieties onto the surface,193 represented by Figure 6.5. Different functional 
groups that can provide a variety of surface chemistry when dispersed in water (i.e. 
amine, carboxylic acid, thiol, alcohol, and methyl groups) can be used for studying how 
different surfaces can affect the biodistribution and cell uptake of nanoparticles in the 
human body. Their location and concentration can be visualized and quantified using 
fluorescent magnetic resonance imaging. 
 
Figure 6.5. Magnetic nanoparticle displaying a surface with a combination of alkyne for 








The materials designed and synthesized in this work have great potential for 
fundamental research on materials used for magnetic hyperthermia that is necessary if 
they are to be a viable alternative to current treatments on the market. A water-dispersible 
nanoparticle that can be easily functionalized for a variety of applications, which has 
been presented in Chapter 5, is very important for biological research but material 
development must continue to optimize the number of steps to synthesize these 
specialized materials for them to be a realistic option. 
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CHAPTER 7. CONCLUSIONS 
 
This work has presented the synthesis of a variety of heterobifunctional PEOs that 
were prepared by the anionic ring opening polymerization of ethylene oxide and end 
group modification. The variety of polymers synthesized in Chapter 1 were the 
motivation to develop a specialized heterobifunctional PEO that can be utilized for 
building a water-soluble magnetic nanoparticle complex with functional scaffolding for 
use in an assortment of biological applications. To confirm the versatility of the 
functional scaffolding, it was modified with a variety of fluorescent dyes that could be 
easily observed using photoluminescence. The particles were also modified with two 
dyes simultaneously to demonstrate the multifunctional capabilities that can be very 
useful for targeted therapeutics and diagnostics.  
To improve the biological stability of the magnetic nanoparticles that is needed 
for increased circulation and efficient drug delivery, a specialized heterobifunctional PEO 
and nitroDOPA was attached to a PAA backbone to increase the number of anchoring 
groups that can interact with the iron oxide surface. The increase in biological stability of 
the multi-anchored nanoparticles compared to mono-anchored nanoparticles was 
demonstrated by submitting them to protein and ionic rich environments at elevated 
temperatures while measuring the change in hydrodynamic diameter. 
The ease of customization of these particles was attractive to other research areas 
outside of magnetic hyperthermia of cancer. They were modified with: a tri-saccharide to 
target and cluster E. coli K99; a fluorescent dye to image them in biofilms; and a 
radiotracer that can be used as in vivo biomedical diagnostic probes. These polymer-
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magnetic nanoparticle complexes show great potential for offering an alternative to 
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